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Introduction and aims of this thesis
Introduction
Pelvic Organ Prolapse (POP) arise when the female pelvic organs descent from their
normal position, into or through the vagina. This happens, in particular, with the uterus,
bladder and rectum. A prolapse of the bladder is called cystocele, the anterior vaginal
wall can be seen with physical examination (Figure 1.1). The anterior vaginal wall is
the most common compartment of the vagina to prolapse.1 The urethra may also bulge
into the vagina. Prolapse of the apical compartment includes descent of the uterus or
vaginal vault (after hysterectomy)(Figure 1.2). Prolapse of the posterior compartment
concerns the rectum (rectocele), but can also include the small or large bowel (Figure 1.3).
Prolapses in one compartment, however, are often combined with prolapses in other
compartments.
Figure 1.1: The anterior vaginal wall prolapse
Source: International Urogynecological Association (IUGA)
In the last decade authors have shown significant progress in the understanding of
the pathophysiology and anatomy of pelvic organ prolapse. We now know that the
pelvic organs are supported through a complex interplay involving the pelvic floor
musculature, fascial support, and nervous system.2 Pelvic Organ Prolapse may occur,
due to different defects that result in anterior, apical, or posterior vaginal segment
weakness. Understanding this process has led to changes in the surgical approach of a
challenging clinical problem. Documentation of the maximum descent of pelvic organ
prolapse is best accomplished by using the Pelvic Organ Prolapse Quantification (POP-Q)
system, which is the most commonly used system and provides objective information
4
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Figure 1.2: Prolapse of the apical compartment (uterine prolapse)
Source: International Urogynecological Association (IUGA)
with reproducible results.3,4 Prolapse severity is graded from stage 0 to IV, based upon
the level of descent of the leading edge of the prolapse. Stage I is a mild condition while
stage IV represents complete eversion of the total length of the lower genital tract.
Epidemiology
It is estimated that 50% of parous women have some loss of pelvic floor support, resulting
in prolapse, however only a minority of these women are bothered by this condition.5 In
a multicenter observational study that included over 1000 women presenting for routine
gynaecologic care, the prevalence of pelvic organ prolapse quantification stages was
24% for stage 0, 38% stage 1, 35% stage 2, and 2% stage 3.6 Furthermore, a Dutch
cross-sectional study demonstrated a prevalence of symptomatic pelvic organ prolapse of
11,4% in women aged 45-85 years.7 Of these women 36,5% were diagnosed with stage I,
33% with stage II, 5% with stage III and only 0,5% with stage IV prolapse.8
Risk factors
Many risk factors for pelvic organ prolapse have been suggested. It is likely that the
cause of this disorder is multifactorial, due to a combination of risk factors, varying
from patient to patient.9 The majority of patients with clinically significant prolapse
will have at least two risk factors for the disorder, which cumulate over time, contribute
5
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Figure 1.3: Posterior compartment prolapse
Source: International Urogynecological Association (IUGA)
to worsening of prolapse as a woman ages. Vaginal childbirth is the most frequently
asscociated factor with prolapse, followed by advancing age and obesity.
Other obstetric factors that have been associated with an increased risk of pelvic
organ prolapse, although less consistently, are delivery of a macrosomic infant, prolonged
second stage of labour, forceps delivery and age below 25 at first delivery.10 Furthermore,
genetic predisposition plays an important role in the development of POP because a
positive family history is an important risk factor for POP.11 A meta-analysis of 8 studies
with 1,107 POP patients and 1,941 controls demonstrated that women with POP are
substantially more likely to have family members with the same condition as compared
to women without POP.11
Pathophysiology
The pathophysiology of pelvic organ prolapse is thus multifactorial. The levator ani muscle
complex and the endopelvic fascia are the most important contributors to anatomical
support. The muscles of the levator ani complex are tonically contracted at rest and act
to close the genital hiatus and thus provide a platform for the pelvic viscera. Damage
to the muscles and fibrous structures result in a descent of the vaginal walls and pelvic
organs through the urogenital hiatus. Different types (or combination of compartments)
6
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of prolapse exist in different women. The site at which the muscle is damaged determines
the type of prolapse present.12
Clinical presentation
The most common symptom of prolapse is a sensation of pelvic pressure/heaviness or
protrusion of tissue from the vagina.13 Patients frequently describe this as a feeling of a
bulge in the vagina or outside the vagina. This feeling is less noticeable in the morning
and worsens as the day progresses.
Certain types of prolapse may be associated with specific symptoms. Urinary symptoms
are frequent in women with pelvic organ prolapse. Loss of anterior vaginal support
may lead to a hypermobile bladder neck with stress urinary incontinence. Women
may experience improvement in stress urinary incontinence over time but increased
difficulty voiding due to urethral obstruction by kinking of the urethra and masked
stress incontinence. In case a woman with pelvic organ prolapse leaks only when the
prolapse is reduced this is called masked stress urinary incontinence. Women who void
better when their prolapse is manually reduced also are likely to have masked stress
incontinence. After successfully correcting the prolapse with an operative procedure this
masked incontinence can be unmasked with overt incontinence as a result.
Furthermore, women with pelvic organ prolapse frequently complain of symptoms
related to bowel dysfunction. Anterior protrusion of the rectum into the vagina (rectocele)
can cause defecatory dysfunction. In severe cases, the patient may have to splint the
posterior vagina in order to defecate. Women may complain of impairment of sexual
relations. One third of the sexually active women with pelvic organ prolapse complain
of dyspareunia or mechanical obstruction for intercourse.14 However, the presence and
severity of symptoms are not strongly correlated with the stage and site of prolapse and
more than one site may be affected.10
To assess the presence and bother of pelvic floor dysfunction, a careful history is taken
and it is recommended to use a validated questionnaire on urogenital (dys)function and
health-related Quality of Life. In the Netherlands questionnaires such as the Urogenital
Distress Inventory (UDI), and the Incontinence Impact Questionnaire (IIQ) have been
validated and are advised by the Dutch Urogynaecologic Society.15 After treatment the
Patient Global Impression of Improvement (PGI) may be used.
Treatment
There are different ways to treat pelvic organ prolapse. Treatment can be divided into
two options; non-surgical and surgical. Non-surgical treatment options are pessaries and
pelvic floor exercises. A pessary is one of the oldest medical devices, and is reported from
the beginning of the recorded history. It is a small plastic, rubber or silicone medical
7
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device, which is inserted into the vagina and held in place by the pelvic floor musculature.
Pessaries are used in daily practice by more than 86% of gynaecologists and 98% of
urogynaecologists.16,17 This non-invasive treatment option may relieve symptoms of POP
in 50 to 80% of women.18 After 5 years 14 to 48% of the women still use this pessary for
their prolapse.18
Pelvic floor exercise is a method by which women learn be aware of the muscles of the
pelvic floor and strengthen the pelvic floor muscles. Pelvic floor exercises, physical therapy,
and behavioural modification (dietary modifications and timed voiding/defecation) can
be helpful in controlling symptoms in women with mild prolapse. However, the evidence
for this treatment is scarce; only one study suggested that a pelvic floor exercise program
was effective to prevent worsening of genital prolapse in the women who had severe
genital prolapse.19 A third non-surgical option is expectative management, since prolapse
is rarely a life-threatening condition and many women have no symptoms or discomfort.
Surgical treatment may be inevitable if non-surgical options fail or in case of severe
prolapse. There is an estimated lifetime risk of undergoing a surgical procedure for POP
and/or urinary incontinence varying from 11 to 20%.20−22 It has been reported that every
year roughly 13.000 women undergo vaginal prolapse surgery in the Netherlands. In the
coming years it is expected that this number will increase, since in 2040 the number of
women aged 65 years old or more will have doubled.23
Reconstructive surgery for pelvic organ prolapse aims to correct the anatomy of
the vagina while maintaining (or improving) vaginal sexual function and relieving any
associated pelvic symptoms. Surgery can be undertaken by either vaginal or abdominal
route, several studies suggested that the preferred route for primary prolapse surgery is
the vaginal route, approximately 80-90% of operations for prolapse are performed this
way.22,24
The most frequent approach for correction of prolapse of the anterior vaginal wall
is anterior colporrhaphy. Anterior colporrhaphy is a surgical procedure that aims to
reinforce the fascial layer between the bladder and the vagina (Figure 1.4). The success
rate of this procedure ranges from 80-100% in case series to 40-60% in randomized
trials.25−28 The reason for this low success rate is unknown. Success rates in other
compartments are higher, posterior colporrhaphy treats around 80-88% of the women
with a posterior vaginal wall prolapse successfully. Transvaginal apical suspension
procedures claim recurrence rates of 0-15%.29−31 Of women who will undergo surgery,
13-17% will undergo a re-operation for pelvic organ prolapse or urinary incontinence.32,33
Given these high reoperation rates, synthetic material may be used in surgical repairs in
an attempt to improve outcomes. Data from randomized controlled trials demonstrated
significant reductions in anatomic failure rates when synthetic mesh was used.34−36 Side-
effects associated with the use of mesh in the vagina are mesh exposure and shrinkage.
This may result in pain, dyspareunia and vaginal discharge, sometimes requiring (partial)
removal of the mesh.36−39
8
1
Introduction and aims of this thesis
Figure 1.4: Schematic presentation of the anterior colporrhaphy
Source: International Urogynecological Association (IUGA)
Thesis ”Surgery for Pelvic Organ Prolapse with emphasis
on the anterior compartment”
Anterior vaginal wall prolapse is common and the anterior colporrhaphy is the most
frequent approach of correction. Unfortunately recurrence after surgery is high. This
thesis attempts to provide insight into the effectiveness of surgery for POP with emphasis
on anterior vaginal wall surgery. To obtain this insight we studied the history of and
the exact technique of anterior colporrhaphy. In addition the variation in techniques of
anterior colporraphy and the use of mesh amongst Dutch gynaecologists was studied.
We studied the thickness of the removed vaginal tissue in relation to various dissecting
techniques. We investigated the changes in urinary incontinence after POP surgery,
and we identified risk factors for urinary incontinence after surgery for pelvic organ
prolapse. Since the anterior compartment is most vulnerable compartment with respect
to recurrence after POP surgery, vaginal mesh is increasingly used, especially in this
compartment. New meshes and new mesh-techniques are developed to reduce their
complications. However, few comparisons of different meshes or techniques are published.
We compared two different vaginal mesh systems.
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The aims of this thesis are:
• To present an overview of the history of anterior colporrhaphy, surgical procedures
and other practices concerning pelvic organ prolapse (Chapter 2).
• To evaluate the variation in technique of anterior colporrhaphy, and the use of mesh
in pelvic organ prolapse surgery among members of the Dutch Urogynaecologic
Society (Chapter 3 and 5).
• To investigate the difference in thickness of the removed anterior vaginal wall
between surgeons using different surgical dissecting techniques of anterior colpor-
rhaphy (Chapter 4).
• To compare failure rates and complications in patients undergoing trocar guided
vaginal mesh repair (Prolift®) versus trocar guided partially absorbable mesh
(Prolift+M®) repair in pelvic organ prolapse surgery (Chapter 6).
• To study changes in urinary incontinence rates pre- and postoperatively in surgery
for pelvic organ prolapse (Chapter 7).
• To identify risk factors that predict the presence of symptoms of urgency urinary
incontinence or stress urinary incontinence after surgery for pelvic organ prolapse
(Chapter 7).
10
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Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
Abstract
Introduction: The objective of this work was to collect and summarize a detailed
historical review of the surgical treatment of pelvic organ prolapse (POP) in which we
specifically focused on the anterior compartment.
Methods: A literature search in English, Dutch and German was carried out with
the keywords pelvic organ prolapse, anterior colporrhaphy, cystocele and interposition
operations in several databases (e.g. Pubmed and HathiTrust Digital Library). Other
relevant journal and textbook articles were found by retrieving references cited in previous
articles and textbooks.
Results: Probably the first explanation of the treatment of pelvic organ prolapse dates
from 1500 B.C. The Egyptians gave a description to ’falling of the womb’ in the Kahun
papyrus. More than a millennium later, Euryphon, a contemporary of Hippocrates (400
B.C.) described some interesting therapeutic options, from succusion (turning a women
upside down for several minutes) to irrigation the displaced uterus with wine. A wide
range of techniques have been attempted to repair the prolapsing anterior vaginal wall.
By 1866, Sim had already performed a series of operations very similar to a modern
anterior repair. The first reviews about the abdominal approach to correcting a cystocele
were in 1890. The first description of using mesh in the repair of cystoceles was the use
of tantalum mesh in 1955. In 1970, the first report of collagen mesh in urogynaecology
was described. Nowadays, the robotic assisted surgery and cell based tissue engineering
are the latest inventions.
Conclusion: Many surgeons have tried to find the ideal surgical therapy for anterior
compartment prolapse, but to date, this has not been achieved.
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Introduction
In 1909, Ahlfelt stated that the only problem left unresolved in plastic gynaecology was
the permanent cure of cystocele.1 Surgical management of cystocele remains problematic
even today, with a profusion of surgical options available. We collected and summarized
a detailed historical review of the surgical treatment of pelvic organ prolapse (POP)
in which we specifically focused on the anterior compartment. As some procedures,
such as Burch colposuspension, have the goal to cure both anterior wall prolapse and
stress urinary incontinence (SUI), there can be an overlap between the two conditions.
Where appropriate, this will be mentioned in the text. Due to the overwhelming amount
of literature, particularly in the last decennia, it is impossible to present a complete
overview of all the literature. We attempted to present the most relevant developments
with regard to the history of anterior vaginal wall surgery.
Materials and Methods
A search of literature in the English, Dutch, and German languages was carried out using
the keywords pelvic organ prolapse, anterior colporrhaphy, cystocele and, interposition
operations in several databases (e.g. Pubmed and Hathi Trust Digital Library). Articles
that might yield additional original observations but not identified by our search, as
well as literature published before 1966, were sought by pulling references cited in the
retrieved articles. We also identified articles by searching bibliographies in gynecology
and anatomy textbooks related to POP.
Review
Ancient History
Probably the first explanation of the treatment of pelvic organ prolapse dates from
1500 B.C. The Egyptians gave a description to ’falling of the womb’ in the Kahun
papyrus.2 More then a millennium later, Euryphon, a contemporary of Hippocrates (400
B.C.) described some interesting therapeutic options, from succussion to irrigation of
the displaced uterus with wine.2−4 He described the succussion as follows: After the
patient had been tied to a ladder-like frame she was tipped upward so that her head was
towards the bottom of the frame (Figure 2.1). The frame was then moved upward and
downward more or less rapidly for approximately 3-5 minutes. As the patient was in an
inverted position, it was thought that the prolapsing organs of the genital tract would
be returned to their normal position by the force of gravidity as well as the shaking
motion. Hippocrates also suggested that wet feet, excessive exertion, fatigue, sexual
excesses and especially a recent delivery were all aetiological factors in the development
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of prolapse.2 Hippocrates’ son-in-law Polybus wrote in On Diseases of Women that a
prolapsed uterus was treated by the use of local astringent lotions, a natural sponge
packed into the vagina, or the placement of half a pomegranate in the vagina.2,4 No new
findings or descriptions on prolapse were published or were localised for quite a while.
Then, 350 years A.D, Soranus advised another therapy. A half pomegranate should
be dipped into vinegar before inserting, and even greater success, the patient should
be placed on bed rest with reduced fluid and food intake. If the uterus had not been
replaced by the succussion method, the legs were tied together for three days.2
Figure 2.1: Demonstration of the Hippocratic succusion.2
16th till 19th century
It was more than a millenium, 1521, until Berengario da Carpi is reported to have
performed the first surgical procedure for a prolapse. The procedure involved placing a
rope around the prolapsed uterus, which was tightened for a few days until the organ was
ischaemically damaged. The stump was treated with a mixture of wine, honey, and aloe
herbs.2 In 1603, Rodericus a Castro proposed another treatment for uterine prolapse.
The surgeon should ”attack it with a piece of iron” (red hot) as if to burn it, whereupon
”fright” will force the prolapsed part to recede into the vagina.2,3
Study of anatomy flourished in the 17th and 18th centuries. Invention of the printing
press facilitated the exchange of ideas. Peyer, a Swiss gynaecologist, gave the first
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description of a cystocele in the seventeenth century.5 Peyer was also one of the first
who recognized that both the uterus and the bladder were able to prolapse. In the 18th
century, gynaecologists around the world more and more began to realize the importance
of the aetiology of POP. Halder stated in 1730 that an important cause of prolapse was
difficult and protracted labour and when the fetal head was retained in the pelvis for a
long period of time.2 This theory is still widely supported and regarded as one of the
most important causes of POP.
The 18th century led to great progress in the terminology of prolapse. In dictionaries
of the late 17th and early 18th centuries, descriptive terms were already being used, such
as prolapsus uteri and prolapsus of the bladder.6 The terminology was quite similar to
that used nowadays, namely, uterine prolapse, relaxation of the anterior wall (cystocele),
relaxation of the posterior wall (rectocele), true pelvic hernia (enterocele), and procidentia
or total prolapse.
19th Century
In the mid 19th century, surgery took a major step forward due to the use of anesthesia,
allowing the option of longer duration of operations. Furthermore, the development of
surgical techniques, the adaptation and improvement of suture materials (silver, catgut,
or silk sutures), and the important influence of the antiseptic theories of Joseph Lister,
led to great progression in the surgical management of a prolapse.7,8
The first surgical repair of a cystocele probably was done on a cadaver. The Frenchman
Geradin suggested in 1823 a dissection of the vaginal mucosal membrane but without
readapting the edges.9 In 1830, Dieffenbach, surgeon to the Charity Hospital in Berlin,
performed the first dissection (denudation) of the vaginal mucosa on living women. As
knowledge and experience grew, in 1834, Mende´ introduced the concept of dissecting and
readapting the edges. Huguier suggests in 1859 that a high amputation of the cervix was
a solution for the problem of elongation and pointed out the existence of an avascular
space between the bladder, cervix and vaginal wall.10
The first true anterior colporrhaphy was performed in 1866 by Sim (Figure 2.2).11
This operation was very similar to those of today, but Sim did not continue this kind of
surgery for a long period of time, probably because he invented a new technique that
was more simple without dissection of the entire thickness of the vaginal wall (with less
cicatrisation).11 He performed two ovoid or wedge-shaped excisions of the rendundant
full thickness but thinned vaginal wall. These two excisions were closely united with
seven silver sutures (Figure 2.3).
In the 1870s, several variations and modifications of the anterior colporrhaphy were
performed; for example, by Emmet.12 Emmet found that in case of an urethrocele the
operation of Sim did not always provide the solution. He improved the operation of Sim
by making another incision, as represented in Figure 2.4.
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Figure 2.2: Sim’s operation for cysto-
cele (1866).11
Figure 2.3: Sim’s operation with exci-
sion of two ovoid or wedges
of the redundant full thick-
ness but thinned vaginal
wall (1866).11
Figure 2.4: Emmet’s operation for cystocele (modification of Sim’s operation) before
and after. After suturing a triangle CAD is formed (1880).12
There were different opinions for what the best approach would be for the direction of
the vaginal incision (vertical or horizontal). Reed stated in his 1901 textbook that in
case of a large cystocele, a transversal dissection was preferred so that the resulting line
of approximation was more according to the normal folds of the vagina (Figure 2.5).13
No information about shortening of the vagina after transverse excision was described.
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Figure 2.5: Transverse dissection in anterior colporraphy by Reed so that the resulting
line of approximation was more according to the normal folds of the vagina
(1901).13
Thomas, a surgeon from the USA, invented several instruments to facilitate anterior
colporrhaphy.14 Figures 2.6 and 2.7 shows two of these instruments: The first is a device
which was used to separate the bladder from the vagina. The second device was a special
clamp (”three inches long, with blades half an inch wide, and having two rows of teeth,
a quarter inch in length, fixed upon their inner faces”) at which the two flaps of the
separate vaginal wall were brought together. The portions of the vaginal wall hanging
out of the clamp were cut off, and sutures were applied to the lips of the wound to ensure
that the clamp was held in place. Forty-eight hours after the operation the clamp was
taken off.
Figure 2.6: Thomas’ dilating forceps for separating the bladder and vagina.14
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Figure 2.7: Thomas’ vaginal clamp with teeth for compressing wound in vagina for
treatment of cystocele.14 The two flaps of the separate vaginal wall were
brought together. The portions of the vaginal wall hanging out of the clamp
were cut off and sutures were applied to the lips of the wound to ensure
that the clamp was held in place.
A new innovation in 1877 by LeFort was the total vaginal occlusion operation, which
is now better known under the name LeFort-Neugebauer colpocleisis (this operation
is similar to the one described by Neugebauer in 1881 in Germany).15,16 This surgical
procedure is still in use. Another surgical procedure that remains in practice is the
Manchester Fothergill. In 1888, Manchester combined an anterior vaginal wall repair
with an amputation of the cervix and a perineorrhaphy. A modification of this procedure
by Fothergill in 1912 led to one of the most widely used procedures in the 20th century
for a uterine prolapse.17,18 The circular incision around the cervix, which Fothergill
proposed, exposed more widely the base of the uterosacral and cardinal ligaments, which
he transposed to the anterior side of the cervix to add to the uterine support. It is
interesting that this idea was argued recently by DeLancey who described the important
relationship between cystocele and apical descent.19 It is not known whether this idea
was already recognized by Fothergill or whether he was trying to solve two problems
with one surgery.
Interposition operations
Interposition operations, in which the uterus was positioned between the bladder and
the vaginal wall, were popular at the end of the nineteenth century. The first surgeon
who described and performed this operation of transposition of the uterus and bladder
vaginally was Du¨hrssen in 1894.20 Shortly after Du¨hrssen, in 1896, Freund performed a
similar procedure during an abdominal procedure to avoid injury to the bladder.21 A
modification by Wertheim, Watkins and Schauta was made in the years 1898-1909 and led
to one of the most popular vaginal procedures among surgeons in the first four decades of
the twentieth century (Figure 2.8).22−25 Watkins published a review in 1912 and reported
a success rate between 66.6% and 97.4%.26 The reason that this operation has fallen
into disuse is not entirely clear but is probably related to an increased risk of death due
to a septic peritonitis.25 Another problem was that the operation could only be carried
out safely after menopause, because subsequent pregnancies and menstruation were a
major problem. Furthermore, in the event of the necessity of subsequent hysterectomy,
the surgery might be much more difficult, if not impossible, to perform.25
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Figure 2.8: Watkins-Wertheim interposition operation for cystocele.26
Conservative treatment
In 1859, a Swedish officer and a pioneer in medical gymnastics, Thure Brandt, employed
Swedish medical gymnastics to treat prolapse.27 His therapy consisted of uterine massage
and gymnastics, and in 1858, he claimed to have cured a woman with a complete
prolapse. Such medical gymnastics reached the desired results by means of active and
passive movements, increasing or decreasing the metabolism, regulating resorption in
any given part of the body and increasing general tone. Brandt’s method began with
bimanual massage and so-called ’lifting the uterus’ and regular gymnastics movements
were given.28 Another European physician reported similar success with gymnastic
methods.29 Nevertheless, physiotherapy was not used greatly, and surgeons preferred
surgical methods to cure prolapse.28 Nowadays, pelvic floor exercises are still regarded
helpful in controlling symptoms in women with mild POP. However, the evidence for this
treatment is marginal: only one study suggests that a pelvic floor exercise program was
effective to prevent worsening of genital prolapse in the women who had severe genital
prolapse.30
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Early 20th Century
In the twentieth century there was a growing understanding of the etiology, pathophysi-
ology, and the different surgical procedures in POP. In 1909, White was astonished by
the great risk of recurrence after surgical correction of a cystocele.1 He suggested an
operative procedure that entailed reattaching the vagina to the linea alba of the pelvis
(called ’white line’ because of its colour and not named after White). In this paravaginal
repair of cystoceles, he reported no recurrences. A couple of years later, he reported that
the poor surgical results of anterior colporrhaphy were due to a misunderstanding of
the etiology.31 In his review, he rejected different theories about the etiology regarding
cystoceles: overstretching and thinning of the vaginal wall and other supports of the
bladder, which allow the bladder to descend in the form of a hernia; stretching of the firm
attachment of the bladder to the uterus; and stretching of the ligamentous suspension of
the bladder. He considered these pathophysiological mechanisms irrelevant and described
his autopsy findings regarding the dissection of the anterior vaginal segment. He stated
that the anterior vaginal wall supports the bladder, and when a cystocele occurs, it is due
to the lateral sulci of the vagina breaking away from the attachment of the ischiadic spines
and the white line. However, his theory and recommendation for surgical management
did not gain widespread acceptance and were ignored for the next 60 years until, in 1976,
Richardson and colleagues, inspired by White, published a new controversial look at
pelvic relation and its relationship with fascial defect.32 However neither the abdominal
nor the vaginal paravaginal repair were found to improve the outcomes, and numerous
complications have been reported.33 The debate about central and lateral (paravaginal)
defects is ongoing.34
Abdominal approach
Several reviews about the abdominal approach of cystocele were published a decade
before the twentieth century.35 Wlaccaz and Dumoret suggested the cystopexie, an
operation in which the lateral walls of the bladder were fixated to the abdominal incision
(excluding the skin) with catgut sutures.36 Tuffier, a gynaecologist from France, opted for
another possibility. He fixed the bladder high upon the abdominal wall extraperitoneally
through a transverse suprapubic incision.37 Byford, disliking to interfere with the bladder,
suggested an operation through the inguinal canal (posterior pubic cellular tissue).38
In this colpocystorrhaphy, the entire thickness of the vaginal wall at either side of the
urethra was sutured (with silkworm gut) into the walls of the inguinal canal. In 1898,
Lowson exposed the extraperitoneal area through a abdominal incision and pilled the
hypogastic cords (middle umbilical ligament) upward and secured them to the rectus
muscle.39 Because this method allowed significant recurrences, he adapted it so that the
bladder was sutured to the umbilical peritoneum as well. With this method 19 of 25
patients considered themselves as ’never been better’ after 3 months.
In 1961, Burch described a new operative procedure for the correction of SUI and
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cystocele: urethrovaginal fixation of the anterior vaginal wall to Cooper’s ligament.40 This
operative approach obviated the problem of inability of the Marshall-Marchetti-Krantz
procedure to reduce a cystocele.41 Burch described 53 patients with SUI and cystocele
and a satisfactory correction of the anterior vaginal wall was obtained in all patients.
For many years, the Burch colposuspension was the gold standard approach to which
other operations for SUI were compared. A systematic review demonstrated that the
long-term success rates to cure SUI of the Burch procedure range from 61 to 100%,
although complications occurred in up to 41% of patients.42 However, in that period it
was seldomly used or described as a primary operation for curing cystocele. A major
problem of the Burch colposuspension, and probably other coarse anatomical corrections,
is the higher risk of postoperative genital prolapse in the posterior vaginal compartment,
particularly the occurrence of an enterocele.43 A modification of the Burch procedure
was described by Tanagho in 1976 44 Tanagho placed his sutures in a far lateral position,
used two sutures bilaterally, and emphasized avoidance of undue tension on the anterior
vaginal wall. Another modification of the Burch colposuspension is the retropubic
colpourethropexy.45 This abdominal surgical procedure is a combination of the original
Burch procedure with a wedge colpectomy. In this procedure, anterior wedge colpectomy
and wedge resection of the pubocervical fascia was performed (Figure 2.9). Weinstein
and Roberts first described the wedge colpectomy in 1949.46 Later, Macer (1978), Drutz
(1991) and Quadri (1997) described this type of surgery as a way of correcting anterior
vaginal wall relaxation.45,47,48 The danger of abdominal anterior wedge colpectomy lies
in the dissection of the bladder base from the underlying vaginal wall with an inherent
risk of ureteral damage. The risk of cystocele relapse differed from 0 to 10%.
The Kelly/Kennedy operation
At the beginning of the First World War, Kelly introduced a new pioneering technique
for the correction of urinary incontinence by plicating the ’relaxed tissues at the vesical
neck’ with interrupted mattress sutures at the time of an anterior colporrhaphy.49 His
procedure was quickly adopted and became standard of care for the next 60 years for
SUI. Minor modifications were performed by Kennedy in 1937, which included dissection
of the urethra from the vaginal wall, with plication of the injured sphincter muscle at
the urethrovesical junction.50 Both of these procedures remained very popular because
of the ease with which they could be performed at time of prolapse surgery, although
they had relatively poor long-term success rates. Only 40 years later, a well-researched
study showed that the long-term results (after 10 years) of the so called Kelly/Kennedy
procedure were not as good as anticipated, with a high recurrence rate of SUI and
especially the problem of urinary retention.51
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Figure 2.9: Abdominal surgical procedure which is a combination of the original Burch
procedure with a wedge colpectomy. An anterior wedge colpectomy and
wedge resection of the pubocervical fascia are performed.45
Late 20th century
Over the course of the 20th century, textbooks were becoming increasingly important.
Every textbook about vaginal surgery described a different technique for an anterior
colporrhaphy, but most of the time, differences were small.52−56 An interesting theory on
thickness of the removed anterior vaginal wall was presented in the textbook of Nichols
and Randall.52 They described three methods of removal of anterior vaginal wall in
the classic anterior colporrhaphy, and there was no report of the existence of a vaginal
fascia. Whether or not a vaginal fascia really exists is still a matter of debate, but the
latest published articles corroborate the idea that the surgical ’fascia’ have the histologic
appearance of moderately dense connective tissue and thus do not exist.57,58
In 1989, Raz described the four-corner bladder suspension for moderate cystocele and
SUI.59 This vaginal operation restores anterior vaginal wall prolapse with support of
the bladder base and reposition of the bladder neck in the high retropubic position. He
accomplished this by placing a second set of sutures at the cystocele base. The four
sutures were transferred suprapubically by a ligature carrier and sutured to the anterior
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rectus fascia. A comparison showed that the midurethral sling procedure had a higher
long-term cure rate compared with the Burch colposuspension and the four corner needle
suspension procedures.60
In 1991, DeLancey presented his theory on the supporting structures in the pelvis
investigated in cadaveric dissections.61 This theory is the basis for many textbooks and
clearer understanding of the etiology of POP. He compared the anterior vaginal wall to a
hammock for supportting the bladder and bladder neck. This hammock-like structure is
divided in three levels, each with their own support and attachments.
Mesh
Disappointing outcomes of operations for the management of anterior vaginal wall
prolapse have encouraged surgeons to experiment with a variety of natural (autologous
and xenogenous) and synthetic grafts. The first traceable description of using mesh
in the repair of cystoceles was the use of tantalum mesh in 1955.62 This material was
used because of the success of tantalum plates in the treatment of SUI without adverse
effects.63 Exposure of the tantalum plate was common (four of nine cases) but the study’s
authors did not regard this as a problem at that time. Granulation tissue progressively
covered the defects in the vaginal wall. Researchers searched for other materials suitable
for use in humans, and in the 1970s, the first report of xenogenous collagen mesh in
urogynaecology was described. In 1970, Friedman et al. described the use of reconstituted
collagen yarn mesh in four patients (of whom two had previous surgery for prolapse) with
a follow up of 2-4 years.64 No complications or recurrent prolapse was reported. In 2000,
the use of xenogenous tissues for repair of cystocele was reported .65 The use of porcine
collagen implants aimed to reduce the prolapse recurrence rate, although Dahlgren et al.
found similar recurrence rates for conventional repair compared with using porcine skin
graft.66,67 In 1992, Zacharin described the use of excised vaginal epithelium (autologous
tissue) as a free full thickness skin graft during surgery for recurrent POP.68 Gleadell
had suggested this idea earlier in 1952.
The use of non-absorbable synthetic mesh started around the beginning of the 1990s.69
Julian used polyprolene Marlex mesh in anterior colporrhaphy; there were only three
erosions (mesh exposures) and no failures in the Marlex group. Due to the exposure
rate in several studies, fully absorbable mesh was used in the end of the 1990s.34,70
Polyglycolic acid or polyglactin-10 were the two most frequently used materials, but
probably due to the disappointing long-term results, they fell into disregard.34 The
search for the ideal material for mesh in POP is ongoing. In trying to reduce potential
adverse effects and complications medical device companies have been modifying mesh
materials. Partially absorbable mesh is one such material that possibly lowers the erosion
rate, in balance with better success rates than conventional surgery. A systematic review
showed that anatomical recurrence rates for anterior colporrhaphy were lower when using
non-absorbable mesh compared with using xenograft or absorbable mesh.71 Risks of
graft exposure, wound granulation, and dyspareunia are comparable between all different
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synthetic and biological graft materials.72 Mesh development has not focused exclusively
on the material but also on the surgical fixation. For example, mesh augmentation,
which is mesh that was used in conventional vaginal prolapse repair for patients with
recurrent symptomatic prolapse.73,74
21th Century
Cell-based (stem cells) tissue engineering strategies could possibly provide attractive
alternatives to native tissue repair. In urogynaecology, mainly SUI, cell-based injection
therapy to regenerate the urethral sphincter is being explored.75 However, using cell-
based strategies to treat POP has been only sparsely explored in preclinical studies,
certainly compared to the repair of inguinal and femoral hernias.75
Another invention of the 21th century is the robotic assisted surgery. In particular,
treatment of the apical prolapse has evolved in the adoption of the robotic assisted
laparoscopic sacrocolpopexy.76 In other pelvic compartments, robotic surgery is used
little. The inability to perform concomitant surgery for other forms of nonapical prolapse
or SUI without repositioning or making a second incision is an important disadvantage.76
Conclusion
This review clearly indicates that many surgeons have attempted to find the ideal
surgical therapy for anterior compartment prolapse, which to date has been unsuccessful
(Figure 2.10). It is questionable whether at this time we perform better surgeries than a
century ago. The use of modern light weight non-absorbable mesh looks promising with
regard to efficacy, but the side effects are an issue of major concern. Reports on these
products (by e.g. FDA) has lead to the withdrawal of mesh kits by major companies.
New developments are likely to come from basic research, such as stemcell therapy or
other forms of tissue engineering. While preventing POP still in its infancy, it will be
necessary to search for the most appropriate therapy for this long standing and historical
problem.
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Figure 2.10: Timeline from the nineteenth and twentieth century for pelvic organ
prolapse surgery with emphasis on the anterior compartment.
31
Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
References
1. White GR. Cystocele radical cure by suturing lateral sulci of vagina to white line
of pelvic fascia. JAMA 1909;53:1707-10.
2. Emge LA, Durfee RB. Pelvic organ prolapse: four thousand years of treatment.
Clin Obstet Gynecol 1966 Dec;9(4):997-1032.
3. Peckham-Murray G. Mechanism and treatment of complete procidentia uteri Am
J Obstet Gynecol 1895;29:648-65.
4. Rawls RM. Cystocele; review of the literature, with a further preliminary report
of an operation for its relief. Am J Obstet Gynecol 1918;78:328-47.
5. Peyer JK. Parerga anatomica et medica septem: Observatio circa urachum in
foetu humano pervium, ut et ... Observationes quaedam anatomicae: J. Delbeek
& G. Boot; 1750.
6. Phillips E, Kersey J. The new world of words: or, Universal English dictionary.
Containing an account of the original or proper sense, and various significations of
all hard words derived from other languages ... Together with a brief and plain
explication of all terms relating to any of the arts and sciences ... to which is
added, the interpretation of proper names: Printed for J. Phillips; 1706.
7. Sims JM. Silver sutures in surgery: Samuel S. & William Wood, New York; 1858.
8. Lister JB, Meeting BMA. On the Antiseptic Principle in the Practice of Surgery:
The lancet; 1867.
9. Geradin R. Memoire presente a la societe medicale de Metz en 1823. Arch Gen
Med 1825;8.
10. Huguier. Memoires sur les allongements hypertrophiques du col de l’uterus. Paris
1860.
11. Sims JM. Clinical notes on uterine surgery: Robert Hardwicke; 1866.
12. Emmet TA. The principles and practice of gynaecology. Philadelphia: H. C. Lea;
1880.
13. Reed CAL. A Textbook of gynecology. New York: Appleton & co.; 1901.
14. Cowperthwaite AC. A text-book of gynecology: designed for the student and
general practititioner. Chicago: Gross & Delbridge; 1888.
15. LeFort LC. Nouveau proce´de´ pour la gue´rison du prolapsus ute´rin. Bull Gen Ther
1877;92:337-46.
32
2Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
16. Neugebauer LA. Einige Worte u¨ber die mediane Vaginalnaht als Mittel zur Beseit-
igung des Geba¨rmuttervorfalls. Centralb f Gynakologie 1881;23:369.
17. Fothergill WE. A Clinical Lecture on the precise relationship of cystocele, prolapse
and rectocele, and the operation for their relief: Delivered in the Post-graduate
Course at the Manchester Royal Infirmary. Br Med J 1912 Apr 13;1(2676):817-8.
18. Classic pages in obstetrics and gynecology. Anterior colporrhaphy and its com-
bination with amputation of the cervix as a single operation. William Edward
Fothergill. Journal of Obstetrics and Gynaecology of the British Empire, vol 27,
pp. 146-147, 1915. Am J Obstet Gynecol 1977 Oct 15;129(4):457-8.
19. Delancey JO. Surgery for cystocele III: do all cystoceles involve apical descent? :
Observations on cause and effect. Int Urogynecol J 2012 Jun;23(6):665-7.
20. Du¨hrssen A. Ueber die operative Heilung der mobilen und fixirten Retroflexio uteri
auf vaginalem Wege, mit besonderer Beru¨cksichtigung der Dauererfolge. Archiv
fu¨r Gyna¨kologie 1894;37:447.
21. Freund WA. Centralb f Gynakologie 1896;20:1009.
22. Watkins TJ. The treatment of cystocele and uterine prolapse after the menopause.
Am J Obstet Gynecol 1899;15:420-3.
23. Wertheim E. Zur plastischen Verwendung des Uterus bei Prolaps. Centralb f
Gynakologie 1899;23:369.
24. Schauta F. U¨ber Prolapsoperationen. Gyna¨k Rundschau 1909;3:729.
25. St. George Wilson J. Transposition (Interposition) of the Uterus for Severe
Uterine and Vaginal Prolapse. BJOG: An International Journal of Obstetrics &
Gynaecology 1938;45(4):655-62.
26. Watkins TJ. Transposition of the uterus and bladder in the treatment of extensive
cystocele and uterine prolapse. Am J Obstet Gynecol 1912;65:225-42.
27. Brandt T. Nouvelle me´thode gymnastique et magne´tique pour le traitement des
maladies des organes du bassin: et principalement des affections ute´rines: Fritze;
1868.
28. Hogner R. On the value of kinesitherapy in gynecologic practice. JAMA: The
Journal of the American Medical Association 1895;XXIV(4):115-9.
29. Profanter P. Die Manuelle Behandlung des Prolapsus Uteri. Wien; 1888.
33
Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
30. Piya-Anant M, Therasakvichya S, Leelaphatanadit C, Techatrisak K. Integrated
health research program for the Thai elderly: prevalence of genital prolapse and
effectiveness of pelvic floor exercise to prevent worsening of genital prolapse in
elderly women. Journal of the Medical Association of Thailand = Chotmaihet
thangphaet 2003 Jun;86(6):509-15.
31. White GR. An anatomical operation for the cure of cystocele. Am J Obstet
Gynecol 1912;65:286-90.
32. Richardson AC, Lyon JB, Williams NL. A new look at pelvic relaxation. Am J
Obstet Gynecol 1976 Nov 1;126(5):568-73.
33. Maher C, Baessler K. Surgical management of anterior vaginal wall prolapse: an
evidencebased literature review. Int Urogynecol J Pelvic Floor Dysfunct 2006
Feb;17(2):195-201.
34. Weber AM, Walters MD, Piedmonte MR, Ballard LA. Anterior colporrhaphy:
a randomized trial of three surgical techniques. Am J Obstet Gynecol 2001
Dec;185(6):1299-304; discussion 304-6.
35. Annual of the universal medical sciences. In: Sajous CE, editor. http://
archiveorg/stream/1891annualofuniv02philuoft/page/n7/mode/2up: F.A. Davis; 1888.
p. H48-H9.
36. Wlaccaz, Dumoret. Revue me´dico-chirurgicale des maladies des femmes, Paris
1890.
37. Tuffier TL. Socie´te´ de me´decine et de chirurgie de Bordeaux. Gazette hebdomadaire
des sciences me´dicales de Bordeaux 1890;11.
38. Byford HT. The Cure of Cystocele by Inguinal Suspension of the Bladder; Colpo-
cystorrhaphy. Am J Obstet Gynecol 1890 Feb;23:152.
39. Lowson D. An operation for elevation of the female bladder in prolapse or cystocele.
Br Med J 1898;23:232-4.
40. Burch JC. Urethrovaginal fixation to Cooper’s ligament for correction of stress
incontinence, cystocele, and prolapse. Am J Obstet Gynecol 1961 Feb;81:281-90.
41. Marshall VF, Marchetti AA, Krantz KE. The correction of stress incontinence by
simple vesicourethral suspension. Surg Gynecol Obstet 1949 Apr;88(4):509-18.
42. Dainer M, Hall CD, Choe J, Bhatia NN. The Burch procedure: a comprehensive
review. Obstet Gynecol Surv 1999 Jan;54(1):49-60.
34
2Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
43. Wiskind AK, Creighton SM, Stanton SL. The incidence of genital prolapse after the
Burch colposuspension. Am J Obstet Gynecol 1992 Aug;167(2):399-404; discussion
-5.
44. Tanagho EA. Colpocystourethropexy: the way we do it. J Urol 1976 Dec;116(6):751-
3.
45. Quadri G, Magatti F, Belloni C, Mattioli G. Transabdominal repair of cystocele
by wedge colpectomy during combined abdominal-vaginal surgery. Int Urogynecol
J Pelvic Floor Dysfunct 1997;8(5):278-83.
46. Weinstein M, Roberts M. Simultaneous repair of cystocele and high rectal prolapse
during total hysterectomy. West J Surg Obstet Gynecol 1949 Jan;57(1):34-7.
47. Macer GA. Transabdominal repair of cystocele, a 20 year experience, compared with
the traditional vaginal approach. Am J Obstet Gynecol 1978 May 15;131(2):203-7.
48. Baker KR, Drutz HP. Retropubic Colpourethropexy: Clinical and Urodynamic
Evaluation of 289 Cases. Int Urogynecol J 1991;2:196-200.
49. Kelly HA, Dumm WM. Urinary incontinence in women, without manifest injury
to the bladder. 1914. Int Urogynecol J Pelvic Floor Dysfunct 1998;9(3):158-64.
50. Kennedy W. Incontinence of urine in the female, the urethral sphincter mechanism,
damage of function, and restoration of control. Am J Obstet Gynecol 1937;34:576-
89.
51. Glazener CM, Cooper K. Anterior vaginal repair for urinary incontinence in women.
Cochrane Database Syst Rev 2001(1):CD001755.
52. Nichols DH, Randall CL. Vaginal surgery: Williams & Wilkins; 1989.
53. Te Linde RW, Mattingly RF. Te Linde’s Operative gynecology: Lippincott; 1977.
54. Ka¨ser O, Ikle´ FA, Hirsch HA. Atlas of Gynecological Surgery: Including Urological,
Proctological and Mammary Procedures: G. Thieme Verlag; 1985.
55. Brewer JI, DeCosta EJ. Textbook of gynecology: Williams & Wilkins; 1967.
56. Shaw W, Howkins J. Textbook of operative gynacology: Williams and Wilkins;
1960.
57. Farrell SA, Dempsey T, Geldenhuys L. Histologic examination of ”fascia” used in
colporrhaphy. Obstet Gynecol 2001 Nov;98(5 Pt 1):794-8.
35
Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
58. Lensen EJ, van den Berg-van Erp SH, Stoutjesdijk JA, Hasaart TH, Withagen MI,
Kluivers KB, et al. Does the method of dissecting in anterior colporraphy lead to
a difference in thickness of removed vaginal tissue? Eur J Obstet Gynecol Reprod
Biol 2013 Jan 21.
59. Raz S, Klutke CG, Golomb J. Four-corner bladder and urethral suspension for
moderate cystocele. J Urol 1989 Sep;142(3):712-5.
60. Kilicarslan H, Guvenal T, Ayan S, Gokce G, Cetin A, Gultekin EY. Comparison
of outcomes of three different surgical techniques performed for stress urinary
incontinence. Int J Urol 2003 Mar;10(3):126-30; discussion 31.
61. DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J
Obstet Gynecol 1992 Jun;166(6 Pt 1):1717-24; discussion 24-8.
62. Moore J, Armstrong JT, Willis SH. The use of tantalum mesh in cystocele with
critical report of ten cases. Am J Obstet Gynecol 1955 May;69(5):1127-35.
63. Goldberger MA, Davids AM. The treatment of urinary stress incontinence by the
implantation of a tantalum plate. Am J Obstet Gynecol 1947 Nov;54(5):829-37.
64. Friedman EA, Meltzer RM. Collagen mesh prosthesis for repair of endopelvic
fascial defects. Am J Obstet Gynecol 1970 Feb 1;106(3):430-3.
65. Ruparelia B, Gunasheela S, Sundar K. Anterior and Posterior vaginal prolapse
repairs with porcine skin collagen (PelvicolTM) implant. Int Urogynecol J Pelvic
Floor Dysfunct 2000;11(Suppl 1):FDP33-S45.
66. Meschia M, Pifarotti P, Bernasconi F, Magatti F, Riva D, Kocjancic E. Porcine
skin collagen implants to prevent anterior vaginal wall prolapse recurrence: a
multicenter, randomized study. J Urol 2007 Jan;177(1):192-5.
67. Dahlgren E, Kjolhede P. Long-term outcome of porcine skin graft in surgical
treatment of recurrent pelvic organ prolapse. An open randomized controlled
multicenter study. Acta Obstet Gynecol Scand 2011 Dec;90(12):1393-401.
68. Zacharin RF. Free full-thickness vaginal epithelium graft in correction of recurrent
genital prolapse. Aust N Z J Obstet Gynaecol 1992 May;32(2):146-8.
69. Julian TM. The efficacy of Marlex mesh in the repair of severe, recurrent vaginal pro-
lapse of the anterior midvaginal wall. Am J Obstet Gynecol 1996 Dec;175(6):1472-5.
70. Safir MH, Gousse AE, Rovner ES, Ginsberg DA, Raz S. 4-Defect repair of grade 4
cystocele. J Urol 1999 Feb;161(2):587-94.
36
2Surgical treatment of pelvic organ prolapse: a historical review with emphasis on the
anterior compartment
71. Jia X, Glazener C, Mowatt G, MacLennan G, Bain C, Fraser C, et al. Efficacy and
safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall
prolapse: systematic review and meta-analysis. BJOG 2008 Oct;115(11):1350-61.
72. Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG. Incidence
and management of graft erosion, wound granulation, and dyspareunia following
vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol
J 2011 Jul;22(7):789-98.
73. Baessler K, Maher CF. Mesh augmentation during pelvic-floor reconstructive
surgery: risks and benefits. Curr Opin Obstet Gynecol 2006 Oct;18(5):560-6.
74. Milani AL, Heidema WM, van der Vloedt WS, Kluivers KB, Withagen MI,
Vierhout ME. Vaginal prolapse repair surgery augmented by ultra lightweight
titanium coated polypropylene mesh. Eur J Obstet Gynecol Reprod Biol 2008
Jun;138(2):232-8.
75. Boennelycke M, Gras S, Lose G. Tissue engineering as a potential alternative or
adjunct to surgical reconstruction in treating pelvic organ prolapse. Int Urogynecol
J 2012 Sep 1.
76. McIntyre M, Goudelocke C, Rovner ES. An update on surgery for pelvic organ
prolapse. Curr Opin Urol 2010 Nov;20(6):490-4.
37
3
Technique of anterior colporrhaphy: a
Dutch evaluation
E.J.M. Lensen, J.A. Stoutjesdijk, M.I.J. Withagen, K.B. Kluivers and
M.E. Vierhout
Technique of anterior colporrhaphy: a Dutch evaluation. Lensen EJ,
Stoutjesdijk JA, Withagen MI, Kluivers KB, Vierhout ME. Int Urogynecol
J. 2011 May;22(5):557-61. Epub 2011 Feb 25.
Technique of anterior colporrhaphy: a Dutch evaluation
Abstract
Introduction and hypothesis: To evaluate the variation in techniques of anterior col-
porrhaphy amongst members of the Dutch Urogynecologic Society.
Methods: A questionnaire evaluating the technique of anterior colporrhaphy, pre- and
postoperative care and use of the POP-Q score was sent out by email.
Results: 133 completed questionnaires were received. The response rate was 65%.
There are large variations in incisions, use of hydrodissection, method of plication, and
excision of redundant vaginal epithelium. The urinary catheter was generally removed
on day 2 after surgery and vaginal pack on day 1. Less than half of the respondents used
the POP-Q score routinely.
Conclusions: Dutch gynecologists use a variety of surgical techniques to operate on a
cystocele. This suggests that there is no widely accepted opinion on the best surgical
approach. The lack of differentiation between central and lateral defects is striking and
in contrast with the, mostly, American literature.
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Introduction
Pelvic Organ Prolapse (POP) is known to effect up to 50% of women with a lifetime
risk of undergoing surgery for POP or incontinence of 11%.1 Recurrence rates after
surgery are high and especially anterior vaginal wall prolapse is known to recur frequently,
with recurrence rates following a anterior colporrhaphy anywhere between 0 - 92%.2 To
prevent recurrence of a cystocele after repair, different techniques have been used, for
example paravaginal repair (abdominal or vaginal), ultralateral anterior colporrhaphy
and the use of different grafts and meshes. All these different techniques, except the use
of grafts, have had disappointing results to date. Studies comparing techniques have
shown no differences in the risk of recurrence.3 In 2008, Shippey described a survey of
the American Urogynecologic Society (AUGS) members of the contemporary approaches
to cystocele repair.4 Their research mainly compared the differences between generalist
and fellowship trained urogynecologists.
Since a number of Dutch studies also showed comparable poor anatomical outcome
of anterior colporrhaphy, we decided to evaluate the variation in techniques of anterior
colporraphy amongst members of the Dutch Urogynecologic Society in an attempt to
get more insight in the variation of techniques and potentially find a reason for the high
recurrence.5,6
Materials and Methods
All members of the Dutch Urogynecologic Society received an email, explaining the
research question and asking for their cooperation in an internet-based survey. A link in
the email directed them to a website containing an internet-based questionnaire. The first
email was sent in February 2010. A month later a reminder was sent to the gynecologists
who have not yet responded. A final reminder was sent by ordinary mail instead of an
email.
The survey included 40 questions on demographics, current employment and training
background. To evaluate the diagnostic process we asked if and how they differentiated
between central and lateral defects, and how this influenced their surgical technique. In
addition, their use and opinion on the POP-Q score was questionned. Various questions
on techniques used in surgical repair of a cystocele, use of prophylactic antibiotics
and pre-and postoperative care were included. To identify the precise variation in
surgical techniques, we asked about the use and type of solution used for hydrodissection,
location and length of incision, technique of dissection, type of suture material, excision
of excessive vaginal mucosa and the way of suturing. Furthermore, questions were asked
on postoperative care relating to the use of a catheter and vaginal packing and the day
of removal. The survey was conducted anonymously. The respondents were assigned a
number in order that reminders could be sent. No financial compensation was given.
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Data analysis was performed using Statistical Package for the Social Sciences, version
18.0 (SPSS inc., Chicago, Ill., USA). Continuous variables were compared using the
independent-samples t-test or Mann-Whitney U test. Categorical variables were compared
using the chi-square test. Related samples were compared using the paired-samples
T-test or the Wilcoxon signed rank test. A p-value of <0.05 was considered statistically
significant.
Results
In total 239 questionnaires were sent, but 25 respondents did not belong to the target
group (retired or resident). Nine questionnaires could not be delivered, leaving 133
respondents (65%). Respondents’ characteristics are described in table 3.1.
Table 3.1: Characteristics of survey respondents
Characteristics N =133 (%)
Gender
Male 60 (45)
Female 73 (55)
Years since residency
<5 45 (34)
5-10 29 (22)
10-20 31 (23)
>20 28 (21)
Practice type
Academic center 12 (9)
Peripheral training hospital 77 (58)
Peripheral, non-training hospital 44 (33)
Data presented as number (percentage)
Diagnosis
Three-quarter of the participants (77%) responded that they use the POP-Q, of whom
only 52% routinely. There were no significant differences between the use of the POP-Q
and practice type (p>0.05).
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Thirty-two percent (n=42) of the respondents differentiated between central and
lateral defects. When they do, differentiation between the two types is made by physical
examination, whereby the gynecologist usually inspects the presence of vaginal rugae.
By the absence of rugae, a central defect is considered more likely. By the respondents
who do differentiate between the two types, a change in operation procedure is however
only seldom made. In case of a lateral defect, a small number of gynecologists (n=14)
perform an anterior colporrhaphy with graft augmentation. No vaginal or abdominal
paravaginal repair was reported.
Preoperative care
All respondents use local hormone therapy from time to time in post-menopausal women;
58% use hormone therapy only when they diagnose vaginal atrophy. Routine peri-
operative antibiotics is given by 80 (60%) of the respondents.
Technique of colporrhaphy
Before the incision, 76% use hydrodissection, for which most commonly a saline solution
is used with or without adrenaline (41% resp 24%) (Table 3.2). Most respondents (77%)
make a simple midline incision, although 17% make an inverted T-form incision from the
cervix to the urethra. When the participants were asked for the most urethral point of
incision the majority (56%) place the incision near the vesico-urethral juncture, 19% one
cm or less from the urethral meatus and 11% below (proximal of) the vesico-urethral
juncture.
To dissect the bladder, mainly scissors are used (43%), besides the knife (20%), blunt
dissection (7%) or a combination of these techniques (30%). Furthermore, 43% of the
participants attempt to dissect the vaginal mucosa as thin as possible from the bladder,
47% consider thickness less important and dissect in the most optimal surgical plane.
Table 3.3 presents the specifications of the suture material used for plication of the
(remnants of) the vaginal fascia.
For closure of the vaginal wall, opinions were divided: 32% used simple interrupted
stitches, 32% used a continuous locking stitch and 35% of the respondents used a running
(non-locking) stitch. Excessive distended vaginal epithelium is trimmed by 51% of the
respondents depending on the amount of tissue, 4% never trim vaginal epithelium and
45% always do so (Table 3.2).
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Table 3.2: Technique of colporrhaphy
N = 133 (%)
Hydrodissection
Yes 101 (76)
No 32 (24)
Type of hydrodissection (N = 101)
Saline 41 (41)
Saline with adrenaline 24 (24)
Local anesthetic 2 (2)
Local anesthetic with adrenaline 34 (34)
Dissection bladder
Knife 27 (20)
Scissors 57 (43)
Blunt dissection 9 (7)
Combination 40 (30)
Trimming of excess vaginal epithelium
Always 60 (45)
Depends on the amount of tissue 68 (51)
Never 5 (4)
Data presented as number (percentage)
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Table 3.3: Specifications suture materials and method for plication
N = 133 (%)
Suture material
Vicryl® (polyglactin 910) 130 (98)
Monocryl® (poliglecaprone 25) 3 (2)
Thickness suture material
1 7 (5)
0 8(6)
2-0 113 (85)
3-0 5 (4)
Plication in anterior colporrhaphy
Simple interrupted stitches 43 (32)
Continuous locking stitches 43 (32)
Running stitches 47 (35)
Data presented as number (percentage)
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Postoperative care
The catheter is generally inserted transurethrally (97%) and the day of catheter removal
was day 1 (24.8%), day 2 (45.1%), day 3 (29.3%) or later (1%). After removal of the
catheter, the accepted residue in the bladder was 150 cc (52.6%) or 100 cc (36.1%).
Most of the respondents (85.0%) insert a vaginal pack as a standard procedure, and they
almost universally remove it one day after surgery (94.7%). Patients were discharged on
average on day 2 and 3 (30.8% resp 54.1%).
No statistically significant differences were found in the comparisons between the
characteristics of the survey respondents (gender, years since residency and practice type
(academic versus non-academic) and the technique of the anterior colporrhaphy or pre-
and postoperative care (p>0.05). No geographic variations could be found.
Discussion
Our findings demonstrate that gynecologists use a variety of surgical techniques to treat
a cystocele. This suggests that there is no clear opinion with regards to the best surgical
procedure. Only one other similar study was found in the literature, however with a
low response rate.4 In that study, members of the AUGS reported a comparable high
variation in techniques. The wide variation in techniques may be a consequence of the
lack of evidence as to what the best practice is. It is unknown which part of the procedure
(diagnosis, pre-, per- or postoperative care) contributes to surgical failure. Our study
shows that there is little difference with regards to items such as use of a vaginal packing,
transurethral catheter and the day of their removal. Likewise, factors such as length of
incision, suturing techniques and suture material are either quite similar or unlikely to
have a great impact on recurrence. Several other items, however, emerge as potentially
important with regard to the explanation for the high recurrence rates.
The majority of the gynecologists does not differentiate between a central and lateral
defects nor is there any adjustment in the surgical technique to address this issue. We are
not aware of any earlier studies in other countries on data for comparison. Most literature
on the differences between the two defects originates from the USA.7,8 Although several
tests to differentiate have been proposed, these tests have never been validated or been
incorporated in an outcome study. Furthermore, the clinical examination of defects in the
anterior vaginal wall support display poor inter- and intraexaminer agreement.9 In other
words it is unclear how to differentiate between the two and it has never been shown
that differentiation results in a better outcome. Nonetheless, theoretically the location
of a defect is an interesting and potentially important issue. With the availability of new
diagnostic possibilities such as MRI and ultrasound, as well as new surgical techniques
using synthetic grafts, new possibilities for the differentiation and tailoring the right
operation to the right patient are becoming available.10−12 At present, a study on the
validity of MRI and ultrasound for this purpose is being performed in the Netherlands.13
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The use of the vaginal paravaginal repair was remarkably low in our questionnaire, since
only 2 gynecologists reported to consider vaginal paravaginal repair for lateral defects. No
respondent reported the use of an abdominal paravaginal repair. This is in sharp contrast
with the recommendation given in the report from the last International Continence
Initiative (ICI-2009) where the abdominal route has been advised.14 Possibly, the use of
paravaginal repair in the Netherlands has remained low because of the disappointing
results from earlier studies.3,15
The use of synthetic grafts was not part of the present study. At present it is advised
by the Dutch Urogynaecologic Society not to use grafts in primary surgery.
Another potentially important item is the dissection of the vaginal mucosa from the
underlying tissue. Practices were divided regarding this issue. Older textbooks use the
term ’as thin as possible’ in the description of the traditional colporrhaphy.16 In the
more recent literature this is not mentioned.16,17 However, there is no scientific evidence
on the best dissection of vaginal mucosa. We hypothesized that making the vaginal
mucosa as thin as possible was something of ”a lost art” and therefore practiced by older
gynecologists, but this could not be confirmed in our study (p=0.56). Possibly it is
more relevant how and where the gynecologist was trained but this was not part of our
questionnaire. We think thinness of preparation is a potential important issue, which
should be studied, preferably in a well-designed RCT.
It was interesting to see that a number of practices is widely used without much evidence
to support them. For example, three-quarters of the respondents used hydrodissection
before the incision with varying types of solution. Whether this practice has any advantage
is not known. Almost two-third of the respondents used prophylactic antibiotics in
anterior colporrhaphy. These findings are high in reflection of the lack of evidence with
regards to this issue. There is only one single study, from Nieminen et al, which has
reported that prophylactic use of antibiotics seemed effective in the reduction of the
postoperative infection rate in vaginal surgery.18
Almost half of the respondents removed the transurethral catheter on day 2 after
surgery. However two randomized trials have found that in case of removal of the catheter
on the morning after surgery the majority of the patients does not encounter voiding
problems.19,20 Furthermore, two studies have shown that 3 hours of vaginal packing
would be as sufficient for the prevention of post-operative haemorrhage or haematoma
as vaginal packing for 24 hours.21,22 Therefore, it is somewhat surprising that 95 % of
the respondents remove the vaginal pack one day after surgery.
The findings that the POP-Q score is not widely used, suggest that the POP-Q score
does not meet the doctor’s needs, which is in line with earlier publications.23 Less than
half of those surveyed use the score routinely. The measurement of redundant parameters
is the most common comment on the POP-Q score. A quarter of the participants find
the POP-Q score a time-consuming task. Surprisingly, there was no statistical difference
in use of POP-Q score between gynecologist from academic, peripheral training and
non-training hospital.
47
Technique of anterior colporrhaphy: a Dutch evaluation
We recognize several limitations of this study. A survey is always a simplification
of the reality. It is impossible to question all minor details of the surgical technique,
which will be influenced by various details of the surgical anatomy and expertise of the
surgeon. Another important issue is that from this study we are not able to analyze which
technique leads to a higher recurrence. We did not specifically ask for the recurrence
rates in our questionnaire because of a low reliability of the answers without objective
outcome measures. A strength of this study is that 65% of all members of the Dutch
Urogynecologic Society responded to the questionnaire.
This study has raised many research questions in need of further investigation. The
variation of techniques used is a reflection of the absence of a clearly defined best practice.
A well designed prospective study investigating the differences in techniques, with special
attention to differentiation between lateral and central defects is clearly lacking.
In conclusion we found a wide variation of techniques used for anterior colporraphy
in the Netherlands. We consider the lack of differentiation between central and lateral
defects the most striking finding, which should be further studied in a prospective study.
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Does the method of dissecting in anterior colporraphy lead to a difference in thickness of
removed vaginal tissue?
Abstract
Objective: To evaluate the difference in thickness of the removed anterior vaginal wall
between different surgical dissecting techniques of anterior colporrhaphy.
Study Design: In patients undergoing primary anterior colporrhaphy, trimmed vaginal
tissue was taken from different surgical techniques of vaginal wall dissection. Tissues was
preserved in formalin and stained with hematoxylin-eosin and Elastica von Giesen. The
examiner was an experienced pathologist blinded for surgical technique. The specimens
were examined for the epithelial thickness (ET), lamina propria thickness (LPT), muscular
layer thickness (MT) and total thickness (TT).
Results: Tissue from the anterior vaginal wall was analysed in 93 women who had
undergone anterior compartment pelvic organ prolapse surgery. There was no difference
in thickness measured in the 3 histological layers and for the total thickness between
the different surgical techniques. Although, the use of hydrodissection was the only
independent factor leading to a thicker removed vaginal tissue.
Conclusions: Dissecting the vaginal wall as thin as possible does not result in a thinner
vaginal layer than dissecting in the most optimal surgical plane. The use of hydrodissec-
tion provides a thicker trimmed tissue.
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Introduction
Anterior colporrhaphy is the standard surgical treatment for anterior vaginal wall prolapse.
This operation has a high risk of recurrence; recurrence rates from 30% up to 92% are
mentioned.1−3 A cause for this recurrence has not yet been found. Furthermore, there is
little known on the detailed surgical technique of the anterior colporrhaphy in comparison
with the recurrence rates. One of the many possible differences in techniques could be
the way in which the vaginal wall was dissected from the underlying bladder.
In 2010 we reported that approximately half of the gynaecologists in the Netherlands
attempt to dissect the vaginal wall from the underlying tissue as thin as possible.4
The other half considered thinness less important and dissects in the most optimal
surgical plane. Theoretically this is an important technical issue, which could explain
differences in recurrence. There are however no comparative studies between the two
techniques. Also whether the variation between techniques is substantial or merely a
semantic difference is unknown. It is at present a particular topic subject since it is
advised to perform a ”full thickness” dissection when placing a vaginal mesh to decrease
the rate of mesh related complications.
The aim of this explorative study was to resolve one of the controversies on the
importance of vaginal wall thickness in surgical pelvic organ prolapse (POP) repair.
This prospective cohort study compares ”dissection in most optimal surgical plane” with
”dissection as thin as possible” in anterior colporrhaphy. In addition we studied the effect
of hydrodissection on the thickness of the removed tissues.
Materials and Methods
Vaginal wall specimens were obtained from women having a traditional native tissue
anterior colporrhaphy procedure. The specimens were consecutively collected from
surgery done from October 2010 till December 2011 at three different Dutch institutions,
Radboud University Nijmegen Medical Centre, Canisius Wilhelmina Hospital Nijmegen
and Catharina Hospital Eindhoven. The institutional ethical review board gave an
exemption for the protocol because the tissue handling was anonymous.
Women who underwent previous pelvic prolapse surgery in the anterior compartment
or women who underwent an anterior mesh procedure were excluded. Four gynaecologists,
all very experienced in prolapse surgery, performed the operations.
Surgical technique
The vaginal wall was grasped with two Allis clamps, one at the level of the urethra-
vesical junction and one at the level of the cervix or vaginal vault. Two out of the four
surgeons used hydrodissection of approximately 20 cc fluid to assist in identifying planes
of dissection. The vaginal wall was then opened in the midline using knife and scissors
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and the vaginal mucosa dissected off the underlying tissues anteriorly (sharp or blunt
dissection). Two of the four gynaecologists attempted to dissect the vaginal wall as
thin as possible. In their technique they attempt to leave as much of the tissue of the
vaginal wall on the bladder by sharp dissecting the vaginal wall with knife and/or scissors,
whereas the other two considered thinness not important and dissected in the most
optimal surgical plane (Figure 4.1). In this way four different groups arose (Table 4.1).
After the vaginal wall had been dissected, plication of the remnants of the vesico-vaginal
fascia was performed with a series of interrupted Vicryl 0 stitches. Once plication of the
defect had been performed, the mucosa was trimmed and closed. The trimmed tissue
was collected and preserved in formalin.
Figure 4.1: Schematic representation of the different dissection method
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Tissue handling
Each tissue sample was identified only by a number, ensuring that the pathologist
was blinded as to the surgical procedure. Tissues were stained using hematoxylin-
eosin and Elastica-van Gieson for differential staining of collagen and other connective
tissue. The specimens were examined microscopically for histologic content as well
as for the determination of epithelial thickness (ET), lamina propria thickness (LPT),
muscular layer thickness (MT) and total thickness (TT) (Figure 4.2). Epithelium and
lamina propria together form the mucosa. With the muscular layer we measured all
the tissue that lies deeper than the lamina propria. In some thicker specimen there
is also measured adventitia in the muscular layer, because the part of the adventitia
bordering the muscularis is very difficult to establish. The macroscopic thickest region
was measured. From each patient two pieces of tissue were available (from each side of
the midline incision). Of each fragment 1 to 2 representative slides were embedded, from
the thickest region, except when there was a pinch artefact of that particular region.
For the calculation we have used an average thickness per patient. Subject variables
were collected onto a data collection sheet and entered into a study database. Variables
included age, menopausal stage and use of hormone replacement therapy (HRT) (local
or systemic).
Statistical analysis
Since no earlier data were available on this subject no formal power calculation could be
performed; a convenience sample of 80 was chosen (20 each group). When at least 20
patients in each group were included, we stopped collecting. Data analysis was performed
using Statistical Package for the Social Sciences, version 18.0 (SPSS inc., Chicago,
Ill., USA). Continuous variables were compared using the independent-samples t−test,
categorical variables were compared using the chi-square test. Multiple linear regression
(MLR) was computed to identify which variables were independent predictors of the
thickness of the anterior vaginal wall. Variables that achieved significance (p < 0.05) in
the full method of MLR were entered in a subsequent analysis with a stepwise method.
A p−value of <0.05 was considered statistically significant. The standardized β with
p−value of the multiple linear regression model is presented. The intraclass correlation
coefficient (ICC) (95% CI) was calculated. An ICC of 0.81-1.00 was considered to reflect
excellent reliability.5 Statistical analysis was performed using SPSS 18.0.
Results
Tissue from the anterior vaginal wall was analysed in 93 women who underwent POP
surgery. One slide was excluded because of technical artefacts that impaired visibility of
layers. The characteristics of the patients included into the study are outlined in Table 4.1,
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Figure 4.2: Photomicrograph (x 200 orginal mangification) of trimmed tissue of the
anterior vaginal wall
which is divided according to the surgical procedure and the use of hydrodissection.
Measurements of total thickness of the vaginal wall ranged from 1.80 to 11.0 mm (median
3.85 mm). The intraobserver ICC was 0,86 (0,81-0,91). Figure 4.3 presents the mean
thickness of different layers in the four different groups. None of these differences
were statistically significant. Table 4.2 presents the mean thickness of different layers
compared to the way of dissecting. There were no significant differences between the
way of dissecting and the thickness of the 3 different layers. The ET was thinner (p <
0.001), although the MT and total thickness was thicker when using hydrodissection (p
= 0.006).
Age and menopausal status did not result in a difference in thickness of the three
different layers, but the use of hormone replacement therapy leads to a thicker epithelium
(p = 0.046). Table 4.3 presents the multiple linear regression analyses for all the different
factors. The use of hydrodissection is the only independent factor of influence on the total
thickness of the removed tissue. There is thus no significant difference in the thicknesses
of the anterior vaginal wall between different techniques.
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Table 4.2: Comparison of the thickness of the anterior vaginal wall and different surgical
dissecting techniques
ET LPT MT TT
Dissect as thin as possi-
ble (N=41)
0.29 (±0.09) 1.08 (±0.25) 2.65 (±1.07) 4.02 (±1.15)
Dissect in most optimal
surgical plane (N=52)
0.30 (±0.09) 1.06 (±0.32) 2.35 (±1.17) 3.72 (±1.35)
P-value 0.688 0.817 0.817 0.265
Hydrodissection (N=52) 0.27 (±0.07) 1.11 (±0.32) 2.77 (±1.26) 4.14 (±1.39)
No hydrodissection
(N=41)
0.33 (±0.09) 1.03 (±0.24) 2.13 (±0.83) 3.49 (±0.99)
P-value 0.000 0.179 0.006 0.013
Premenopausal (N=4) 0.38 (±0.06) 1.19 (±0.40) 1.97 (±0.77) 3.54 (±1.19)
Menopausal (N=89) 0.29 (±0.09) 1.07 (±0.28) 2.51 (±1.14) 3.86 (±1.27)
P -value 0.058 0.384 0.349 0.615
No HRT use (N=86) 0.29 (±0.08) 1.06 (±0.26) 2.53 (±1.15) 3.88 (±1.29)
HRT use (N=7) 0.36 (±0.13) 1.19 (±0.52) 1.99 (±0.65) 3.54 (±0.85)
P-value 0.046 0.259 0.232 0.506
Thickness is reported in mm as mean (± standard deviation) with P-value from
independent-samples t-test. ET, epithelial thickness; LPT, lamina propria thickness; MT, muscular
layer thickness; TT, total thickness; HRT, Hormone replacement therapy. Bold indicates variables
reaching statistical significance at the P<0.05 level.
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Figure 4.3: Comparison of the thickness of the anterior vaginal wall in the four different
groups. Thickness is reported in millimeter as mean. P -value from 1
way analysis of variance. ET, epithelial thickness; LPT, lamina properia
thickness; MT, muscular layer thickness
Comments
The present study was designed to determine whether the effect of the way of dissecting
during an anterior colporrhaphy leads to a difference in thickness of the removed anterior
vaginal wall. The study was exploratory explorative and not designed to study the effects
of the two techniques on the anatomic or functional results for which larger groups would
have been necessary to be adequately powered. The results of this study show that there
is no significant difference between the ”thin as possible” and ”optimal surgical plane”
techniques. However, we found a significant difference in the epithelial and muscular
layer thickness whether or not hydrodissection was used. A logical explanation for this
might be that the injection of fluid makes the underlying tissue thicker. Apparently
the fluid is mostly absorbed by the muscular layer (and/or adventitia). We could not
explain the fact that the epithelial layer was thinner in the hydrodissection group. It
might be caused by vasoconstriction in this layer or simply that it is compressed or more
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stretched by the expanding deeper layers. The thickness of the lamina propria layer was
remarkably consistent in all specimens.
A considerable amount of literature has been published on the histological and
anatomical relationship of the vagina, urethra and bladder, particularly concerning the
existence of a vaginal fascia.6−10 Opinions can be divided into two groups: those who
believe that the identification and use of tissue referred to as ’fascia’ is essential achieving
effective anterior colporrhaphy and those who do not believe this. In this study, we
couldn’t find a distinctive layer of fascia in the histology of removed tissues. This finding
corroborates the ideas of Farell (2001), who suggested that the surgical ’fascia’ had the
histologic appearance of moderately dense connective tissue.8
The fact that there is no difference between thin as possible and optimal surgical
plane in this study implies that it is unlikely that this is a clinical relevant difference in
technique. However the key question is not the removed tissue but the amount of tissue
which is left on the bladder. We were not able to measure pre-operatively the total layer,
including the tissue which is left in situ, but it is unlikely that this would have been
different between the groups. In addition one could argue that removal of vaginal tissue
is not effective since during plication the lateral remnants of the fascia are joined in the
midline. By doing this, the vaginal wall has no great additional function in support (see
Figure 4.1). Nichols has described a technique in which a separate layer of ”fascia” is
dissected and used as a support under the bladder. In such a technique a thin dissection
of this layer could have an advantage.11
Da Silva et al have measured vaginal wall thickness in pre-and postmenopausal women
and found, surprisingly, a thicker vaginal wall in postmenopausal women.12 A possible
explanation for this difference in thickness may be the formation of callus in women
with a long-standing prolapse. In our study we could not reproduce this difference. A
limitation of our study however is that the numbers of patients in these groups were
relatively small.
Another interesting finding was that there was a wide variation in the range of the
removed anterior vaginal wall thickness. The difference between the thickest and thinnest
total layer was 9.2 mm. It is difficult to explain this result, but it might be related to
a midline or paravaginal defect. In a lateral defect we would expect a thicker vaginal
wall than in a central defect. Unfortunately, the current study was unable to analyse
these variables. There are no other studies which give information about mean thickness
of the removed vaginal wall, but 11.0mm seems to be unusual high. On reviewing this
particular specimen it appeared that the increased thickness was mainly due to a thicker
adventitia and a second muscular layer.
One source of weakness in this study which could have affected the measurements was
the age variation in the four different groups. However, age did not generate a significant
difference in thickness of the anterior vaginal wall. Also there were some differences in
additional surgical procedures between the various surgeons such as the performance
of a sacrospinous fixation. However this did not differ the technique of dissection of
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the anterior vaginal wall in a specific surgeon. Furthermore, no data are provided
on the follow up. It would be interesting to compare the thickness with the chance
of a recurrent anterior vaginal wall prolapse. The third limitation could be the tissue
shrinkage associated with formalin fixation during histological tissue processing. Boonstra
et al have evaluated cervical tissue shrinkage with formalin fixation and found a total
linear dimensional shrinkage of 15% associated with fixation, alcohol dehydration, and
paraffin embedding.13 This shrinkage certainly has impact on the absolute dimensions,
but is unlikely to effect the comparison between the technique themselves. Despite these
limitations, this study is as far as we know, the first study that compares several different
surgical techniques regarding the thickness of the trimmed vaginal wall. Furthermore,
blinded histopathologic measurements provided a representative and reliable picture.
Obviously a randomised controlled trial with more protocolled surgical techniques and
adequate follow up could provide more definitive evidence, on the relation between
surgical technique and outcome after anterior colporraphy. The present study can and
should be used for powering and designing such a study.
Conclusions
In summary, this pilot study has shown that there was no difference in thickness of
the removed anterior vaginal wall for an anterior colporrhaphy by way of dissecting.
In addition no connective tissue was detected and thus not removed, in neither of the
techniques. Therefore the influence of the way of dissection on the recurrence of prolapse
remains unclear. Obviously this will have to be proven in a properly powered prospective
randomised study with adequate follow-up.
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The use of synthetic mesh in vaginal prolapse surgery; a survey of Dutch
urogynaecologists
Abstract
Objective: To evaluate the use of mesh in vaginal prolapse surgery amongst members
of the Dutch Urogynaecologic Society.
Study Design: A questionnaire evaluating the use of mesh versus native tissue repair in
vaginal prolapse surgery was sent out by email to all members. Some specific questions
on standard measures of infection prevention were included.
Results: One hundred thirty-three completed questionnaires were received. The re-
sponse rate was 65%. Seventy-one (71%)of respondents stated that they apply use
synthetic meshes in their patients. The mean percentage of mesh use in overall vaginal
POP surgery was 14%. Most responders use mesh in recurrent surgery only. Prolift® is
the most commonly used brand. All women received prophylactic antibiotics. Although
only half of the respondents changed gloves.
Conclusions: Meshes are commonly used in the Netherlands. The major indication is
repair of a recurrent prolapse.
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Introduction
Pelvic Organ Prolapse (POP) is a common condition with a prevalence of up to 50% of
the middle aged female population.1 There is an estimated lifetime risk of undergoing a
surgical procedure for POP varying from 11-20%.2−5
Because of the high recurrence rate of POP, recurrent surgery is necessary in 6 to
29% of the women.3,6 Anatomical recurrence is significantly lower when synthetic mesh
is used, than with traditional, native tissue repair.7,8 In recent years, there has been
an increasing amount of literature on the use of synthetic mesh. Most studies had
heterogenous patient populations with both primary and recurrent POP included.
The overall conclusion of the present literature is that mesh surgery results in better
anatomical outcomes than traditional native tissue repair but has equal functional
outcome.9−11
Little information on the use of synthetic mesh in daily practice is however available.
Therefore we decided to evaluate the use of synthetic meshes among Dutch gynaecologists
for the surgical repair of POP.
Materials and Methods
An email was sent to all members of the Dutch Urogynaecologic Society, explaining the
research question and ask for contribution to a survey. All gynaecologists interested in
the pelvic floor can become a member of the Dutch Urogynaecologic Society. A link in
the email directed them to a website containing an internet-based questionnaire. The
first email was sent out in February 2010. One month later a reminder was sent to the
gynaecologists who had not yet responded. A final reminder was sent by letter.
The survey included 40 questions on gender, demographics, current employment and
training background. The first part of the questionnaire dealt with the technique of
anterior repair and results of this evaluation have been published.12 The second part
dealt with the use of synthetic meshes in vaginal prolapse surgery. Although this was
part of the same survey, we decided to publish the part which dealt with vaginal mesh
separately because of the ongoing discussion on the use of vaginal mesh as illustrated
by the recent warning of the FDA.13 Information was obtained whether the respondent
applied vaginal mesh in patients and, if so, in which percentage, for which indications
and which type of mesh was used. Also questions on infection prevention were also
included.
The survey was conducted anonymously. The respondents were numbered to allow for
sending reminders. No financial compensation was given.
Statistical analysis was performed using Statistical Package for the Social Sciences,
version 18.0 (SPSS inc., Chicago, Ill., USA). Continuous variables were compared using
the independent-samples t−test or Mann-Whitney U test. Categorical variables were
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compared using the chi-square test. Related samples were compared using the paired-
samples T-test or the Wilcoxon signed rank test. A p−value of <0.05 was considered
statistically significant.
Results
Two hundred thirty-nine questionnaires were sent out, but 25 of the recipients turned
out not to belong to the target group (retired or resident). Nine questionnaires could
not be delivered. Of the remaining 205 recipients, 133 responded (65%). Respondents’
characteristics are described in table 5.1.
The majority of respondents (71%) used meshes. The brands of mesh kits used were
as presented in table 5.2. Indications to use synthetic grafts are presented in table 5.3.
Items which were considered risk factors for recurrence are presented in table 5.4.
Almost half of the respondents (45.7%) prescribed estrogens postoperative in every
patient when using a synthetic mesh (local or systemic), 26.6% only when they diagnosed
vaginal atrophy and 27.7 % most of the time. All respondents administered prophylactic
antibiotics when using synthetic grafts compared with 60% of the respondents in native
tissue repair. Over half of those surveyed (52.6%) reported that they routinely changed
surgical gloves before inserting the mesh. No statistically significant differences were
found between the characteristics of the survey respondents (gender, years since residency
and practice type (academic versus non-academic) and the use of mesh. In addition no
geographic variations could be found.
Comments
This study shows that almost three quarter of the urogynaecologists in the Netherlands
use synthetic grafts in vaginal prolapse surgery, but the overall use of synthetic mesh in
vaginal POP surgery is low (14.4%). Most urogynecologists use synthetic grafts only in
recurrence repair and not in primary surgery.
In 2008, Shippey et al, reported the use of synthetic mesh among American Urogy-
naecology Society (AUGS) Members.14 Forty-four percent of the AUGS members, who
responded, used synthetic mesh in primary cystocele repair and 42 % used synthetic
mesh in repair of a recurrent cystocele. One unanticipated finding was that general
obstetrician/gynaecologists used synthetic mesh in a larger proportion than the fellowship
trained urogynaecologists (61% vs. 40%; p = 0.005). A similar comparison was found
regarding approach to recurrent cystocele repair (53% vs. 37%; p = 0.022). Shippey et al.
suggested that respondents after a completed fellowship have a more cautious attitude
while awaiting data to document their safety and efficacy. Compared with our findings
use of synthetic mesh in the Netherlands was higher (71%). The Dutch gynaecologist
used synthetic mesh mainly in repair of a recurrent prolapse (72%).
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Table 5.1: Characteristics of survey respondents
Characteristics N=133 (%)
Gender
Male 60 (45)
Female 73 (55)
Years since residency
<5 45 (34)
5-10 29 (22)
10-20 31 (23)
>20 28 (21)
Using vaginal mesh
Yes 95 (71)
No 38 (29)
Percentage of procedures with mesh (n=95)
0-5% 18 (14)
5-10% 37 (28)
10-20% 21 (16)
20-40% 13 (10)
40-60% 4 (3)
60-80% 2 (2)
Data presented as number (percentage)
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Table 5.2: Brand of mesh kit
n=95 (%)
Prolift® (Ethicon, Inc.) 52 (55)
Avaulta® (C.R. Bard, Inc.) 27(28)
Perigee® (American Medical Systems, Inc.) 9 (9)
Elevate® (American Medical Systems, Inc.) 4 (4)
Covidien® (Covidien, Inc.) 3 (3)
Surgisis® (Cook Medical, Inc.) (Biological) 1 (1)
Data presented as number (percentage)
Table 5.3: Reasons to use mesh (multiple responses were permitted)
Reason n=95 (%)
Repair of a recurrent prolapse in the same compartment 68 (72)
Repair of a recurrent prolapse in another compartment 20 (21)
Primary surgery when there is a high risk of recurrence 26 (28)
More than one recurrence after prolapse surgery 4 (4)
Rapid recurrence of pelvic organ prolapse 8 (9)
Data presented as number (percentage)
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Table 5.4: Factors considered to be predictive with regard to recurrence (multiple
responses were permitted)
Risk factor n=133 (%)
Connective tissue disease 72 (77)
Young age 58 (62)
COPD 63 (67)
High stage pelvic organ prolapse 59 (63)
High body mass index 52 (55)
Positive family history 49 (52)
Multiple compartment prolapse 50 (53)
Lateral defects 42 (45)
Smoking 37 (39)
Data presented as number (percentage)
A possible explanation for the difference between the American and our study might
be that the Dutch survey was performed 3 years later. Probably the overall use of
synthetic mesh has increased over the years. This trend is consistent with the study
of Jha and Moran, who found a significant rise in graft usage over the past five years,
particularly synthetic graft for recurrent prolapse.15
In October 2008, the Food and Drug Administration (FDA) issued a warning regarding
serious complication associated with surgical mesh devices for repair of POP or stress
urinary incontinence.16 The FDA formulated several recommendations that should be
taken into consideration before using mesh. In July 2011, a much more critical update was
provided about the serious complications associated with surgical mesh for transvaginal
repair of POP.13 Ostergard has pointed out that an approval from the FDA cannot
be interpreted as confirmation that a graft material is safe or effective.17 An FDA
approval means no more than that the material is substantially ’equivalent’ to an existing
material in use. Ostergard questioned whether the FDA realized the differences in the
technological characteristics between the different devices when clearance for marketing
was provided.17
In 2011, Swift discussed the use of mesh.18 Both approaches, native tissue repair and
synthetic mesh, were regarded ”adequate and to serve the patients well”. All women
undergoing POP repair, and especially when choosing native tissue repair, the patient
should be informed on the risk of a recurrent POP. In case of synthetic mesh, the
patient should furthermore be informed on the risk of mesh complications. The risks of
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a re-operation for recurrent POP in native tissue repair and a re-operation due to mesh
complications are rather similar. Ostergard concluded that we need a comprehensive
study on complications in macroporous, low-weight, small-caliber fiber diameter mesh.19
All respondents who used synthetic meshes provided prophylactic antibiotics. There
are no controlled studies available that compared differences in postoperative infections
in vaginal POP surgery. In open mesh repair of inguinal hernias, Shankar et al. showed
that the routine use of antibiotic prophylaxis in elective mesh repair was not useful.20 In
that randomized controlled study, they found no statistical difference in postoperative
wound infection. It is not known whether the widespread use of antibiotics in vaginal
surgery is necessary. Since the vagina is not a sterile environment and the consequences
of infections are potentially large, antibiotics use is recommended until proven otherwise.
Vollebregt et al. have studied the effect of changing gloves before insertion of the
mesh.21 They found that changing gloves before inserting the vaginal mesh had no
effect on the bacterial contamination of mesh material or on clinical infection rate. In
2000, Zdanowski et al. investigated the incidence of intraoperative graft contamination,
bacterial species and the influence of change of surgeon’s gloves on contamination.22
Their study did not show any effect of gloves change before graft implantation regarding
the number of contaminated grafts either. In another study, Wooster et al (1985) found a
lowering of graft contamination from 56 % to 35 % following change of surgeon’s gloves.23
Altogether, these findings do not provide the evidence that the routine change of surgical
gloves before insertion of the synthetic graft is useful.
Our findings in this report are subject to a few limitations. Most important is that
a survey relies on self-reported data. The main strength of this study was the high
response rate (65%). Another important issue is that from this study, we are not able
to analyze which mesh leads to more complications. We did not specifically ask for the
complication rates in our questionnaire because of a low reliability of the answers without
objective outcome measures.
Conclusions
In summary, we found that almost three quarter of Dutch urogynaecologists used synthetic
meshes in POP surgery, but only in a low percentage of vaginal POP surgeries. The
majority of respondents used mesh in recurrent POP surgery only.
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Comparison of two trocar-guided trans-vaginal mesh systems for repair of pelvic organ
prolapse: a retrospective cohort study
Abstract
Introduction and Hypothesis: The aim of this study was to compare failure and
complication rates in patients that underwent a trocar guided vaginal mesh repair with
either a non-absorbable or a partially absorbable mesh.
Methods: Retrospective analysis of prospectively collected data of consecutive women
undergoing either non-absorbable or partially absorbable mesh for symptomatic stage 2
prolapse or higher were evaluated at 12 months. Outcome measures included objective and
subjective failure rates, patient’s satisfaction, complications and perioperative outcomes.
Results: Five hundred and sixty-nine women (347 with non-absorbable mesh, 222 with
partially absorbable mesh) were included. Failure rates were similar in both groups;
re-operation rate in the untreated compartments was higher in the non-absorbable mesh
group compared to the partially absorbable mesh group (5% vs 1%). Mesh exposure rate
in the non-absorbable mesh group was 12% and 5% in the partially absorbable mesh
group. Other complication and patient satisfaction rates were similar.
Conclusions: Non-absorbable and partially absorbable mesh demonstrated similar
outcome rates at 12 months. The risk for reoperation was lower for partially absorbable
mesh. Mesh exposure rate was significantly lower for partially absorbable mesh group
compared to the non-absorbable mesh group.
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Introduction
Pelvic organ prolapse (POP) is a common condition with a prevalence of up to 50% of
the middle-aged female population.1 There is an estimated lifetime risk of undergoing
a surgical procedure for POP and/or urinary incontinence varying from 11 to 20%.2,3
Of those who will undergo surgery, 17% required re-operation during the 10-year time
period.4 Given these high failure rates, synthetic mesh support can be used in surgical
repairs in an attempt to improve outcomes and their durability. Data from randomized
controlled trials demonstrated significant reductions in anatomic failure rates when
synthetic mesh was used.5,6 Various materials have been used such as biological and
synthetic grafts. Few randomised controls trials compared two different grafts, to assess
the different outcomes and complications.7,8 Until 2012, Prolift® (Ethicon Women’s
Health and Urology, Somerville, NJ) was the most commonly used synthetic mesh kit
for recurrent anterior vaginal prolapse in the Netherlands.9 In trying to reduce potential
adverse effects and complications medical device companies have been modifying mesh
materials. One such material is the Prolift+M® (Ethicon Women’s Health and Urology,
Somerville, NJ), which is composed of a 50-50 blend of monofilament nonabsorbable
polypropylene and absorbable polyglecaprone-25. Within 3 months, polyglecaprone-25
is fully absorbed. In this way the pore size following absorption increases from 2.5 to
3.5 mm. In addition, the weight of the Prolift +M decreases from 57 gm/m2 to 31
gm/m2 after absorption as compared to 45 gm/m2 for the Prolift. Therefore, the porosity
between Prolift and Prolift+M differs from 72.3% vs 66.5% after absorption. Some
preclinical studies suggested that a polypropylene mesh with an absorbable monofilament
reduced mean burst strength and stiffness after implantation.10,11 Because of warp
knitting, Prolift+M provides increased elasticity in the longitudinal direction and has
larger pores compared with Prolift to allow more tissue ingrowth. Prolift+M with its
directional elastic properties, was developed to minimize tissue shrinkage, and possibly
less dyspareunia.12 The primary objective of this study was to determine whether
the newer partially absorbable mesh (Prolift+M) had similar success rates and lower
complication rates compared to the widely utilized non absorbable polypropylene mesh
kit (Prolift) in the management of pelvic organ prolapse.
Materials and Methods
Two retrospective cohorts of prospectively collected data from consecutive women
who underwent POP surgery with either a trocar guided tension free vaginal non-
absorbable mesh or with partially absorbable mesh (Prolift or Prolift+M) were compared.
Data were gathered in two large teaching hospitals in the Netherlands with specific
interest in urogynaecology (Radboud University Nijmegen Medical Centre and Reinier
de Graaf Group Delft). These prospective observational cohorts are part of an ongoing
outcome quality registration project of Radboud University Nijmegen Medical Centre
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the Netherlands, which has been approved by CMO Arnhem-Nijmegen Human Research
Committee, April 2006. From September 2005 till September 2009 the non-absorbable
mesh was the only synthetic mesh kit that was used in the two participating hospitals.
Since October 2009 the two hospitals used the partially absorbable mesh as the standard
synthetic mesh kit. Because of participation in a prospective international multicentre
cohort study, 20 patients were already operated with the partially absorbable mesh kit
in 2008.13 The inclusion period for this study ended in August 2011.
Indication for vaginal mesh surgery at the time was increased risk of recurrence after
pelvic organ prolapse surgery. Increased risk of recurrence was defined as either recurrent
POP stage II or higher and/or primary POP stage III or higher.14,15 Exclusion criteria
were future pregnancy wish or a compromised immune system.
Concomitant sacrospinous ligament fixation or modified Manchester-Fothergill proce-
dures were allowed, as well as concomitant native tissue repairs for the less prolapsed
compartments. These decisions were left to the individual estimation of the surgeon.
Surgeries were performed by 4 gynaecologists with broad experience in pelvic floor
reconstruction and had been specifically trained for the trocar guided transvaginal mesh
procedure by an authorized instructor. All operations were performed according to the
surgical technique that has been described by Fatton et al.16
Preoperatively a single dose of intravenous antibiotic prophylaxis was given to all
patients; an indwelling urinary catheter and vaginal gauze pack were left at completion
of surgery according to local protocol.
Measurements were performed before surgery and at 12 months follow-up. A detailed
urogynaecological history was taken and physical examination performed including pelvic
organ prolapse quantification assessment (POP-Q).17 The Urogenital Distress Inventory
is part of the standardized urogynaecological questionnaire that was used, and has
previously been validated for the Dutch language.18 In this self-completed questionnaire,
patients are asked to state whether stress urinary incontinence (SUI), urgency urinary
incontinence (UUI), pain (lower abdomen or genital area) and dyspareunia (in sexually
active patients) was present or absent.18 In case a certain item was scored positive, the
amount of bother was rated on a 4 point Likert scale ranging from ”no bother at all” to
”very much bother”.
Primary outcome was a composite outcome, whereby failure was defined as: POP > the
hymen and vaginal bulge symptoms or surgical POP-reintervention within 12 months.19,20
Secondary failure outcomes were strictly anatomy based outcomes as proposed by the
National Institutes of Health (NIH):
• failure in the mesh treated compartment with leading edge of prolapse stage II or
higher or re-operation for POP in the treated compartment within 12 months;
• failure in any compartment with leading edge of prolapse stage II or higher in any
vaginal compartment or re-operation for POP within 12 months.17,20
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Other secondary outcomes were patients’ subjective improvement (Patient Global
Impression of Improvement), mesh exposure rate and changes in bother and quality of life
measured by the Urogenital Distress Inventory. Furthermore, complications, re-operation
rates, urinary incontinence, dyspareunia and pain were secondary outcomes as well. Pain,
dyspareunia, SUI, UUI and vaginal bulge symptoms were considered present in case a
patient responded at least ”yes, moderately to quite a bit” to that particular question.18
Considering the number of included patients, this study had 80% power to pick up a
difference of 6,5% between the composite failure rates (two tailed hypothesis, α = 0.05).
A failure rate of approximately 10% for Prolift has been reported in several studies.6,19,21
Statistical analysis was performed using Statistical Package for the Social Sciences,
version 18.0 (SPSS Inc., Chicago, Ill., USA). Continuous variables were compared using
the independent-samples t-test or Mann-Whitney U test. Categorical variables were
compared using the chi-square test. Related samples were compared using the paired-
samples t-test or the Wilcoxon signed rank test, where applicable. A p-value of <0.05
was considered statistically significant.
Results
Between September 2005 and August 2011, 3421 patients underwent pelvic organ prolapse
surgery in the two centers. Six hundred forty-one met the inclusion criteria and underwent
a trocar-guided tension-free vaginal mesh procedure. The 12-month follow-up data were
available for 569 (Non-absorbable 347, partially absorbable 222) patients (89%). Except
for a statistically different, but not clinically relevant small difference in age there were
no significant demographical differences between the two groups. Previous surgery for
prolapse, in particular posterior colporrhaphy, was more prevalent in the non-absorbable
mesh group (Table 6.1).
As shown in Table 6.2 the non-absorbable mesh group consisted of significantly
more concomitant anterior and posterior colporrhaphies (P<0.001 resp P=0.04). There
were differences in peri-and post-operative procedures such as spinal analgesia, hospital
stay and duration of catheterization. Only one patient underwent concomitant anti-
incontinence surgery. It is protocol in the two hospitals not to combine POP surgery
with anti-incontinence surgery, since many patients are cured by POP surgery alone
from pre-existing urinary incontinence.22 Postoperatively SUI, UUI and pain were not
statistically significant between groups (Table 6.3).
Table 6.3 shows that 184 of 347 (53%) women in the non-absorbable and 95 of 222
(43%) women in the partially absorbable mesh group were sexually active at baseline.
Postoperatively these percentages were 57 and 36 respectively. This difference was not
statistically significant. There was no difference in dyspareunia or de novo dyspareunia
between groups at 12 months. The dyspareunia rates were only calculated for the patients
who were sexually active. In the non-absorbable mesh group, there were 44 (12%) mesh
exposures versus 12 (5%) after partially absorbable mesh (P<0.001).
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Table 6.1: Patient’s characteristics
Characteristic
Non-absorbable
mesh (N=347)
Partially absorbable
mesh (N=222)
P
Age (years)a 63.1±11.8 65.4±10,1 0.02
Paritya(n) 2 (0-8) 2 (0-8) 0.57
Body mass index (kg/m2)a 26.0±3.5 26.5±3.7 0.60
Comorbidity 146 (42.1) 89 (40.1) 0.64
Diabetes Mellitus 11 (3.2) 11 (5.0) 0.69
Postmenopausal status (yes) 309 (89) 204 (92) 0.27
Pelvic organ prolapse
Stage 2 124 (35.7) 72 (32.4) 0.42
Stage 3 209 (60.2) 146 (65.8) 0.18
Stage 4 14 (4.0) 4 (1.8) 0.14
POP-Q point baseline
Ba 1 (-3 to 10) 2 (-3 to 9) 0.69
C -4 (-10 to 10) -4 (-10 to 10) 0.76
Bp 0 (-3 to 10) 0 (-3 to 9) 0.22
Previous surgery
Any gynaecological surgery 277 (79.8) 160 (72.1) 0.03
Any POP surgery 235 (67.7) 128 (57.7) 0.02
Vaginal hysterectomy 147 (42.4) 96 (43.2) 0.84
Abdominal hysterectomy 75 (21.6) 35 (15.8) 0.09
Anterior colporrhaphy 150 (43.2) 84 (37.8) 0.20
Posterior colporrhaphy 149 (42.9) 65 (29.3) 0.01
Sacrospinous ligament fixation 8 (2.3) 7 (3.2) 0.54
Sacrocolpopexy 33 (9.5) 14 (6.3) 0.18
Previous incontinence surgery 51 (14.7) 35 (15.8) 0.73
a Data are presented as means (± standard deviation), number of women (percentage) or median
(range). N= number of patients.
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Table 6.2: Perioperative and postoperative data
Non-absorbable
mesh (N=347)
Partially absorbable
mesh (N=222)
P
Anterior vaginal mesh 88 (25) 64 (29) 0.36
Posterior vaginal mesh 128 (37) 80 (36) 0.84
Anterior+posterior vaginal mesh 53 (15) 25 (11) 0.18
Total vaginal mesh 78 (23) 53 (24) 0.70
Concomitant surgery
Vaginal hysterectomy 4 (1) 2 (1) 0.77
Anterior colporrhaphy 13 (4) 0 0.00
Posterior colporrhaphy 10 (3) 1 (1) 0.04
Perineoplasty 9 (3) 2 (1) 0.15
Manchester-Fothergill 3 (1) 0 0.17
Enterocele repair 1 (0) 0 0.47
TVT/TVT-O 5 (1) 0 0.11
Analgesia
Spinal 183 (54) 161 (73) 0.00
General 156 (46) 60 (27) 0.00
Operating time (min) 60 (20-160) 50 (19-120) 0.04
Blood loss (mL) 100 (0-1300) 50 (0-500) 0.00
Duration urinary catheter (d) 2 (0-19) 1 (1-14) 0.00
Hospital stay (d) 3 (0-15) 2 (0-13) 0.00
Data are presented as number of women (percentage) or median (range). N= number of patients.
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Table 6.3: Complications
Non-absorbable
mesh (N=347)
Partially absorbable
mesh (N=222)
P
Bladder perforation 7 (2) 3 (1) 0.55
Rectal lesion 2 (1) 0 0.26
Ureter lesion 0 0
Hematoma 3 (1) 2 (1) 0.96
Repeat surgery for post-
operative haemorrhage
0 (0) 2 (1) 0.08
Prolonged catheterisation 29 (8) 23 (10) 0.42
Cumulative mesh exposure at 12 months
All patients 44/347 (12) 12/222 (5) 0.00
Anterior mesh only 7/88 (8) 3/64 (5) 0.42
Posterior mesh only 19/129 (15) 4/80 (5) 0.03
Anterior and posterior mesh 3/52 (6) 1/25 (4) 0.75
Total mesh 15/78 (19) 4/53 (7.5) 0.06
Urgency urinary incontinence
Baseline 142/312 (46) 86/198 (43) 0.65
At 12 months 106/327 (32) 46/152 (30) 0.64
De novo UUI 25/161 (16) 15/85 (18) 0.67
Stress urinary incontinence
Baseline 150/313 (48) 93/197 (47) 0.88
At 12 months 124/328 (38) 51/153 (33) 0.34
De novo SUI 35/157 (22) 16/77 (21) 0.79
Pain (lower abdomen or genital area)
Baseline 162/310 (52) 96/196 (49) 0.47
At 12 months 83/327 (25) 45/154 (29) 0.37
De novo pain 12/143 (8) 10/70 (14) 0.19
Dyspareunia
Baseline 80/184 (44) 26/95 (27) 0.01
At 12 months 75/197 (38) 25/80 (31) 0.28
De novo dyspareunia 17/89 (19) 9/45 (20) 0.69
Data are presented as number of women (percentage). N= number of patients.
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In the non-absorbable mesh group 17 (39%) of the exposures were surgically treated
versus 5 (42%) in the partially absorbable mesh group within a year. Figure 6.1 illustrates
the exposure rate in relation to the type of mesh and the years in which they were used.
From 2010 onwards non-absorbable mesh was no longer used.
Table 6.4 shows failure rates for all predefined outcomes. The primary outcome, the
composite failure outcome, was 8% for the non-absorbable mesh group versus 4% of the
partially absorbable mesh group, but not significantly different. Strictly anatomically
speaking, overall failure; POP stage II or greater or re-operation, was higher (41%) in
the non-absorbable mesh group compared with the partially absorbable mesh group
(32%)(P=0.03). With regard to the various compartments, the failure rates after posterior
mesh were significantly different (non-absorbable 47% vs. partially absorbable mesh 30%).
Failure rate of the mesh-treated compartments POP stage 2 or greater or re-operation
was 18% for both groups. Re-operation for POP was performed in 22 patients in the
non-absorbable mesh group and in 2 patients of the partially absorbable mesh group,
of which 18 (82%) and 2 (100%) in the untreated compartment, respectively. An equal
amount of patients reported vaginal bulge symptoms after surgery.
As shown in Table 6.5 there were no significant differences between the PGI-I scores
between groups.
Discussion
The purpose of the current study was to determine the differences in outcome after
using non-absorbable versus partially absorbable mesh in POP surgery. In this study
we demonstrated no significant difference between the non-absorbable and partially
absorbable mesh in the primary outcome; the composite outcome failure (8% versus
4%, p=0.07). Despite the considerable sample size of our study, there was no clinically
relevant difference demonstrated between the two groups of mesh. There were less
mesh exposures after the partially absorbable mesh compared with the non-absorbable
mesh procedure (12% vs. 5%, P <.001). More re-operations were performed in the
non-absorbable mesh group, almost exclusively in the untreated compartments (P =.002).
No differences were found in functional outcome measures such as urinary incontinence,
bulge symptoms, pain or dyspareunia.
A possible explanation for the lower exposure rate in the partially absorbable mesh
group is that the partially absorbable mesh initiates a less inflammatory response because
of the lower mesh density. Another explanation may be a decrease in stress shielding of
the underlying vaginal wall after implantation of a lighter weight, more flexible mesh,
which in turn may result in a less stiff vagina.23 Furthermore, the increased experience
could play a role in decreasing the exposure rate, since clinical and surgical experience
have previously shown to be inversely associated with the risk of exposure24. Recently, a
study that compared a light-weight versus a heavier-weight mesh demonstrated a similar
(not statistically significant) difference in mesh exposure rate in favour of the lighter
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Table 6.4: Failure outcomes at 12 months
Non-absorbable
mesh (N=347)
Partially absorbable
mesh (N=222)
P
Composite failure: overall POP >
hymen and bulge symptoms or re-
operation
All patients 26/340 (8) 6/173 (4) 0.07
Anterior mesh only 9/86 (11) 1/56 (2) 0.048
Posterior mesh only 11/127 (9) 1/53 (2) 0.10
Anterior and posterior mesh 6/51 (12) 4/21 (19) 0.42
Total mesh 0/76 0/42
NIH failure: overall POP stage ≥
II or re-operation
All patients 142/347 (41) 70/222 (32) 0.03
Anterior mesh only 45/88 (52) 24/64 (38) 0.10
Posterior mesh only 60/129 (47) 24/80 (30) 0.02
Anterior and posterior mesh 28/52 (54) 10/25 (40) 0.26
Total mesh 9/78 (12) 12/53 (23) 0.09
NIH failure of mesh treated
compart-ment POP stage ≥ II or
re-operation
All patients 64/347 (18) 39/222 (18) 0.80
Anterior mesh only 17/88 (19) 16/64 (25) 0.40
Posterior mesh only 16/128 (13) 3/80 (4) 0.04
Anterior and posterior mesh 22/53 (42) 8/25 (32) 0.39
Total mesh 9/78 (12) 12/53 (23) 0.09
Re-operation for POP 22 (6) 2 (1) 0.002
Mesh-treated compartment 4 (1) 0 0.10
Untreated compartment 18 (5) 2 (1) 0.01
Vaginal bulge symptoms 41/329 (13) 18/162 (11) 0.67
Data are presented as number of women (percentage). N= number of patients. NIH, National
Institutes of Health; POP, pelvic organ prolapse
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Table 6.5: Patient Global Impression of Improvement (PGI-I) after surgery
Non-absorbable
mesh (N=297)
Partially absorbable
mesh (N=155)
P
Very much better 72 (24) 43 (28) 0.42
Much better 153 (52) 78(50) 0.81
A little better 37 (13) 19 (12) 0.95
No change 15 (5) 10 (7) 0.54
A little worse 11 (4) 2 (1) 0.15
Much worse 7 (2) 3 (2) 0.78
Very much worse 2 (1) 0 0.31
Data are presented as number of women (percentage). N= number of patients.
weight mesh.25 Milani et al. published in an international multicentre setting a mesh
exposure rate of 10% after 1 year and 14% after 3 years after using partially absorbable
mesh.13,26 This is in contrast with our findings. One explanation for the difference could
be the multicentre setting in that study and a potential difference in experience in using
mesh.27 Clinical and surgical experience has previously been proven to be inversely
associated with the risk of complications.24 Furthermore, the rate of concomitant vaginal
hysterectomy was low in both groups (1%), In a previous study it has been shown that
concomitant hysterectomy is a risk factor for mesh erosion.28
In line with earlier publications we have used a composite outcome as the primary
outcome for this study. We consider this to be the most clinically relevant outcome
measure since it combines anatomical and patient-centered outcomes with the necessity for
re-treatment.19,20 At 12 months the anatomic outcome of the mesh treated compartments
was not significantly different between groups, while the overall NIH failure outcome
(failure in any compartment) was higher in the non-absorbable mesh group (41% vs.
32%). A possible explanation could be that a stiffer non-absorbable mesh increases
the risk of de novo prolapse in the untreated compartment. This would also explain
the significant difference in re-operation rates between non-absorbable and partially
absorbable mesh (6% vs. 1%), in particular of the untreated compartment. Withagen et
al. already demonstrated that using mesh for POP surgery in one compartment increases
the risk of de novo prolapse in other untreated compartments.29,30 Using this partially
absorbable mesh seems to lower the risk of de novo prolapse in untreated compartments
and thus decreases the risk of a re-operation compared to the original non-absorbable
mesh.
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Figure 6.1: Mesh exposure (at 12 months) in the course of time of the two different
mesh systems. Table shows the number of patients with mesh exposure.
The rates of dyspareunia after surgery (38% and 31%) and de novo dyspareunia (19%
and 20%) were similar to the rates in other publications, and there was no difference
between the non-absorbable and partially absorbable mesh.24,31 However, other authors
reported lower de novo dyspareunia rates.13,32 One explanation for this could be a
difference in definition of de novo dyspareunia. Another explanation could be that in
this study it was allowed to perform concomitant native tissue repairs in other non-mesh
treated compartments. We could not explain the significant difference ( P=0.01) in
dyspareunia before surgery between the two different mesh kits. Given the clinically
relevant high rates of dyspareunia we have observed in this study, we suggest that in
general, surgeons should be hesitant in using these meshes in sexually active women.
The major drawback of this study is a potential bias, originating from the fact that
the two different types of mesh were not used simultaneously but after each other. In
the years preceding the introduction of the partially absorbable mesh the surgeons
increased their experience, patient selections might have changed and certainly per- and
postoperative protocols were adapted. The latter is illustrated by the differences in age
of the patients, the concomitant surgery performed, the more frequent use of spinal
anesthesia and the shorter operation time, duration of catheterization and less blood
loss in the partially absorbable mesh group. Increased experience of the surgeons might
be in favour of the partially absorbable mesh group. The relatively favourable results of
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the partially absorbable mesh group may thus be the combined result of a better patient
selection, greater surgical experience and better properties of the material used. However,
in 2009, when both clinics changed from non absorbable to partially absorbable mesh,
the experience of the surgeons was already established with several hundreds of mesh
repairs in both clinics. In addition the curve in figure 6.1 shows a sharp knick to lower
exposure rates after introducing the partially absorbable mesh in 2009. Other potential
weaknesses of this study were that the examiner at the 12 months follow-up was not
blinded and the relatively short follow-up period of 12 months. However, strengths of
this study are the large sample size and the study’s prospective data registry. Additional
strengths are the use of validated instruments of measurements, such as POP-Q, PGI-I
and UDI.
In conclusion, the use of non-absorbable and partially absorbable mesh resulted in
similar success rates at 12 months. In the untreated compartment, the risk of re-operation
for POP was higher when using non-absorbable mesh. Mesh exposure rates were higher
in the non-absorbable mesh group compared to the partially absorbable mesh group.
However due to the study design it was impossible to know whether this was mainly due
to the mesh properties or the increasing experience of the surgeons or a combination
of both. Other complications and patients’ overall improvements were similar. The
partially absorbable mesh appeared equally effective as the non-absorbable mesh, but
with lesser adverse side effects.
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Urinary incontinence after surgery for Pelvic Organ Prolapse
Abstract
Aims: This study focussed on the changes in urinary incontinence (UI) rates pre- and
postoperatively and identified risk factors which predict the presence of symptoms of
urgency urinary incontinence (UUI) or stress urinary incontinence (SUI) after surgery for
pelvic organ prolapse (POP) without concomitant or previous anti-incontinence surgery.
Methods: All consecutive women who underwent POP surgery without concomitant
or previous anti-incontinence surgery in the years 2004-2010 were included. Assessments
were performed preoperatively and at 1 year follow up, including Pelvic Organ Prolapse
Quantification score and a standardized urogynecological questionnaire (Urogenital
Distress Inventory, UDI). Primary outcome of this study was stress and/or urgency UI
postoperatively. Furthermore, this study measured the improvement or worsening of UI
following surgery using the UDI. Univariable- and multivariable logistic regression with
forward selection procedure was used to identify the risk factors.
Results: Nine hundred and seven (907) patients were included. De novo SUI appeared
in 22% and de novo UUI occurred in 21% of the women. At one year 42% were cured
for UUI and 39% were recovered from SUI by POP surgery alone. The best predictor
for the occurrence of postoperative SUI or UUI was the presence of preoperative SUI
or UUI. BMI and Chronic Obstructive Pulmonary Disease (COPD) were identified as
independent risk factors for postoperative SUI. A recurrence in the anterior compartment
protected against SUI postoperatively.
Conclusions: Preoperative SUI or UUI is the most important predictor of SUI and UUI
postoperatively. BMI and COPD were identified as important risk factors for SUI.
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Introduction
Pelvic Organ Prolapse (POP) is a common condition with a prevalence of up to 50%
among the middle aged females.1 Urinary incontinence (UI) is an even more prevalent
condition in middle aged women.2 The relationship between POP and UI is complex
both with regard to pathophysiology, and changes in relation to surgical correction of
POP. UI and POP probably share some of the same etiological mechanism.3,4
The effect of POP surgery on the presence of stress urinary incontinence (SUI) is
complex. POP surgery can result in cure of SUI, whilst it may induce SUI by unmasking
SUI which preoperatively had been masked by POP. 5,6
A number of studies have reported on the presence of postoperative SUI in relation to
performing incontinence procedures at the time of a POP repair.7−9 The matter is still
subject to a lively debate to perform preoperative tests for masked incontinence, and
whether or not to combine an anti incontinence procedure with a POP repair.10
Most studies regarding UI after POP surgery report on rates of pre-and postoperatively
UI only and disregard rates of improvement or worsening. By looking into the changes
in severity of UI after surgery, a more realistic picture is shown.
The primary objective of this study was to describe changes in SUI and UUI rates
pre- and postoperatively. The second aim was to identify predictors for the presence of
UUI and SUI in a large cohort of women after POP surgery without concomitant SUI
surgery or previous SUI surgery.
Materials and Methods
The study population included consecutive women who underwent POP surgery without
concomitant UI surgery and with or without mesh for POP in two teaching hospitals in
the Netherlands with specific interest in urogynecology, respectively Radboud University
Nijmegen Medical Centre and Reinier de Graaf Group Delft. Both clinics are reserved
in adding an additional anti-incontinence procedure at time of POP surgery due to the
increased risk of complications.11 Both clinics also do not routinely test for the presence
of masked SUI.
Exclusion criteria were concomitant or previous anti-incontinence surgery, and insuf-
ficient knowledge of language. This prospective observational cohort study is part of
an ongoing outcome quality registration project of Radboud University Medical Centre,
which has been approved in April 2006 by CMO Arnhem-Nijmegen Human Research
Committee. This analysis includes all pelvic organ prolapse repairs between 2004 and
2010 with or without the use of mesh. Surgery in the anterior compartment: colpor-
rhaphia anterior or an anterior mesh (anterior Prolift). Colporrhaphia posterior with
digital control or posterior mesh (posterior Prolift) in the posterior compartment.12
Surgery in the apical compartment: high sacrouterine ligament suspension, sacrospinal
fixation, Manchester or apical mesh (total Prolift). The mesh used was the Prolift system
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(Gynecare Prolift Pelvic Floor Repair System, Ethicon, Somerville, NJ), and generally
used in patients with a recurrent POP.
Measurements were performed before surgery and at the 12 months follow-up. A
detailed urogynecological history was taken and physical examination performed including
a pelvic organ prolapse quantification assessment (POP-Q). The Urogenital Distress
Inventory (UDI) is part of the standardized urogynecological questionnaire, and has
been validated for the Dutch language.13 In this self-completed questionnaire, patients
were asked to state whether SUI or UUI was present or absent; and if present, patients
were asked to rate the amount of bother of each symptom on a five-point Likert scale.
Domain scores were composed on the basis of the Likert scale values ranging from 0
(least (or no) bother) to 100 (maximum bother).13
Measurements
Primary outcome of this study was stress and/or urgency UI postoperatively reported
by patients, irrespective of the amount of bother. Furthermore, this study measured
the improvement or worsening of UI following surgery using the UDI. Mixed urinary
incontinence was not calculated because an improvement of one type of incontinence and
the deterioration of the other could produce misinterpretations. Data are presented as
number of women (percentage) or median (range). Univariable logistic regression was used
to identify possible risk factors for SUI and/or UUI. Considered risk factors were patient
age, menopause, body mass index, parity, pelvic organ prolapse stage, anterior mesh,
total mesh, SUI and/or UUI preoperatively, Chronic Obstructive Pulmonary Disease
(COPD), anatomical recurrence in anterior compartment, overall anatomical recurrence,
previous POP surgery, previous hysterectomy, and type of surgery. Odds ratios (OR)
and 95% confidence interval (CI) for SUI and UUI are presented. Multivariable logistic
regression with forward selection procedure was used to identify those variables that
were independently related to SUI or UUI postoperatively. Variables with a P -value<0.1
in the univariable analysis were included in the multivariable analysis. A minimum of 10
events per tested variable has been recommended in literature, and thus all possible risk
factors with statistical significance could be analysed.14 The adjusted OR with 95% CI
of the multivariable model are presented. A P -value <0.05 was considered statistically
significant. Statistical analysis was performed using SPSS 18.0.
Results
One-thousand eleven (1011) consecutive women were screened for inclusion of which 104
women were excluded because they underwent concomitant or previous anti-incontinence
surgery (70 women had previous anti-incontinence surgery). There were no exclusions
on the basis of insufficient knowledge of the Dutch language. Table 7.1 shows the
characteristics of 907 women included in the study. The Patient Global Impression of
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Improvement scores at 12 months showed that 88,2% (n=800) of the women reported
improvement. Figure 7.1 shows the percentages and the domain scores of UUI and
SUI respectively pre- and postoperatively. Furthermore, 327 patients (36,1%) had no
complaints of any UI before surgery and 405 patients (44,7%) had no complaints of any
UI after POP surgery. Of the 327 patients with no complaints of any UI, 88 patients
(26,9%) developed de novo any urinary incontinence. In table 7.2 and 7.3, the potential
risk factors for the presence of postoperative SUI or UUI are presented in a univariable
logistic regression model. In table 7.4 the multivariable analysis of SUI and UUI is
listed. This study identified preoperative SUI, COPD, and high BMI as independent
risk factors for SUI postoperatively (P<0.05). Concerning UUI, preoperative UUI or
any incontinence was an independent risk factor for UUI postoperatively (P<0.05). A
high-grade prolapse (POP-Q stage 3 and 4) in the anterior compartment protects women
for a UUI postoperatively. Anatomical recurrence at 1 year in the anterior compartment
protects women for SUI postoperatively as well.
Figure 7.1: Presence of stress and urgency urinary incontinence pre-and postoperatively
as measured by Urogenital Distress Inventory domain score
SUI: Stress Urinary incontinence
UUI: Urgency urinary incontinence
Data are presented as number of women (percentage) or median (range)
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Table 7.1: Patient’s characteristics
Characteristic N=907
Age (years)a 62 (29-100)
Paritya(n) 2 (0-7)
Body mass index (kg/m2)a 26 (16-42)
Postmenopausal status (yes) 718 (79%)
Pelvic organ prolapseb
Stage 2 377 (42%)
Stage 3 or 4 526 (58%)
Previous pelvic organ prolapse surgery 383 (42%)
2 operations 22 (2%)
3 operations 3 (0.3%)
Type of surgery
Anterior compartment 602 (66%)
Posterior compartment 675 (74%)
Central compartment 75 (8%)
Use of vaginal mesh material 372 (41%)
Mesh including anterior compartment 248 (27%)
Mesh including posterior compartment 265 (29%)
Anatomical recurrence at 1 year (POP-Q>stage1)c 375 (47%)
Symptomatic recurrence at 1 year 199 (22%)
Chronic Obstructive Pulmonary Disease 42 (5%)
a Data are presented as number of women (percentage) or median (range). N=number of patients.
b Note that data on 4 patients are missing
c Note that data on 110 patients are missing
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Table 7.2: Univariable Logistic Regression urgency urinary incontinence
Variable N P-value OR (95% CI)
UUI preoperatively (p) 907 0.000 5.326 (3.974-7.138)
SUI preoperatively (p) 900 0.000 2.613 (1.980-3.448)
Any UI preoperatively (UUI and/or SUI)
(p)
900 0.000 5.478 (3.920-7.657)
Age (y) 907 0.595 1.003 (0.992-1.015)
Body mass index (kg/m2) 891 0.087 1.030 (0.996-1.066)
Parity (n) 880 0.037 1.131(1.007-1.271)
COPD (p) 907 0.053 1.834(0.992-3.391)
Menopause (p) 907 0.661 1.068 (0.797-1.431)
Previous hysterectomy (p) 907 0.063 1.288 (0.986-1.682)
Previous POP surgery (p) 907 0.537 1.089 (0.832-1.425)
Anatomical recurrence at 1 year (p) 797 0.928 1.013 (0.762-1.348)
Anatomical recurrence at 1 year in anterior
compartment (p)
797 0.193 1.216 (0.906-1.634)
POP pre-operative
Stage 2 904 0.073 1.281 (0.977-1.678)
Stage 3 and 4 904 0.073 0.781 (0.596-1.023)
POP pre-operative anterior
Stage 2 904 0.011 1.421 (1.084-1.863)
Stage 3 and 4 904 0.006 0.682 (0.519-0.895)
POP pre-operative posterior
Stage 2 904 0.685 0.945 (0.720-1.241)
Stage 3 and 4 904 0.220 1.221 (0.887-1.681)
Hysterectomy total (p) 907 0.097 1.257 (0.959-1.648)
MESH (p) 907 0.194 0.835 (0.636-1.096)
Anterior MESH (p) 907 0.003 0.629 (0.461-0.858)
Surgery including anterior compartment (p) 885 0.002 0.636 (0.477-0.847)
P, absent code as 0, present coded as 1; —, not selected; POP, pelvic organ prolapse; UUI, urgency
urinary incontinence; SUI, stress urinary incontinence; UI, urinary incontinence.
Bold indicates variables reaching statistical significance at the P<0.10 level and valid for entry in
the selection procedure.
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Table 7.3: Univariate Logistic Regression stress urinary incontinence
Variable N P-value OR (95% CI)
SUI preoperatively (p) 907 0.000 5.731 (4.277-7.670)
UUI preoperatively (p) 896 0.000 2.272 (1.732-2.982)
Any UI preoperatively (UUI and/or SUI)
(p)
896 0.000 5.044 (3.656-6.960)
Age (y) 907 0.255 0.993 (0.982-1.005)
Body mass index (kg/m2) 891 0.001 1.059 (1.024-1.096)
Paritity (n) 881 0.781 0.984 (0.876-1.105)
COPD (p) 907 0.000 3.298 (1.691-6.434)
Menopause (p) 907 0.383 0.876 (0.650-1.180)
Previous hysterectomy (p) 907 0.077 1.270 (0.975-1.654)
Previous POP surgery (p) 907 0.933 0.989 (0.757-1.291)
Anatomical recurrence at 1 year (p) 797 0.118 0.798 (0.601-1.059)
Anatomical recurrence at 1 year in anterior
compartment (p)
798 0.009 0.671 (0.498-0.904)
POP pre-operative
Stage 2 904 0.132 0.810 (0.619-1.059)
Stage 3 and 4 904 0.132 1.229 (0.940-1.607)
POP pre-operative anterior
Stage 2 904 0.288 1.155 (0.885-1.509)
Stage 3 and 4 904 0.288 0.868 (0.664-1.135)
POP pre-operative posterior
Stage 2 904 0.705 1.053 (0.805-1.379)
Stage 3 and 4 904 0.146 0.787 (0.569-1.087)
Hysterectomy total (p) 907 0.280 1.159 (0.887-1.514)
MESH (p) 907 0.895 1.018 (0.779-1.332)
Anterior MESH (p) 907 0.690 1.062 (0.790-1.427)
Surgery including anterior compartment (p) 882 0.540 0.540 (0.686-1.218)
P, absent code as 0, present coded as 1; —, not selected; POP, pelvic organ prolapse; UUI, urgency
urinary incontinence; SUI, stress urinary incontinence; UI, urinary incontinence.
Bold indicates variables reaching statistical significance at the P<0.10 level and valid for entry in
the selection procedure.
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Table 7.4: Adjusted Odds Ratios for the risk of stress or urgency urinary incontinence
postoperatively using multivariable logistic regression with forward selection
procedure
Factor
Urgency urinary
incontinence
(N=863)
Stress urinary
incontinence
(N=777)
SUI preoperatively (p) 6.455 (4.650-8.960)
UUI preoperatively (p) 3.009 (1.972-4.591)
Any UI preoperatively (UUI and/or
SUI) (p)
2.477 (1.534-4.001)
Body mass index (kg/m2) 1.045(1.003-1.088)
Parity (n) —
COPD (p) 3.519 (1.573-7.869)
Previous hysterectomy (p)
Anatomical recurrence at 1 year in
anterior compartment (p)
— 0.610 (0.435-0.856)
POP pre-operative
Stage 2 —
Stage 3 and 4 —
POP pre-operative anterior
Stage 2 —
Stage 3 and 4 0.665 (0.490-0.902) —
Hysterectomy total (p) —
Anterior MESH (p) —
Surgery including anterior compart-
ment (p)
—
P, absent code as 0, present coded as 1; —, not selected; POP, pelvic organ prolapse; UUI, urgency
urinary incontinence; SUI, stress urinary incontinence; UI, urinary incontinence.
Data are odds ratio (95% confidence interval)
Bold indicates variables reaching statistical significance at the P<0.05 level.
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Conclusions
In this large prospective cohort study, we showed trends of UI after POP surgery. A
number of patients developed de novo SUI (22%) and a similar number developed de
novo UUI (21%) after POP surgery. These results are consistent with those of previous
studies.15 Patients without SUI or UUI preoperatively should thus be counseled among
the uncertainty of developing de novo SUI or UUI postoperatively. On the other hand
39% of the women with a pre-existing SUI were (subjectively) cured by POP surgery alone
as were 42% were cured with a pre-existing UUI without concomitant anti-incontinence
surgery. We therefore consider it reasonable to deliberate not performing concomitant
anti-incontinence surgery and first await the effects of POP surgery alone. This finding
is in agreement with Borstad’s findings that showed that 27% of women were cured of
SUI by POP surgery alone.5 Also more women experienced an improvement of their SUI
(19%) than a deterioration (9%) as is demonstrated by the changes in the domain scores
(figure 7.1). Furthermore, concomitant anti-incontinence surgery increases the likelihood
of complications during surgery and the change of prolonged catheterisation.11,16
This study demonstrated that pre-existing UI (SUI and/or UUI) was an independent
risk factor for UUI after POP surgery. The pre-operative presence of a high-grade POP
(stage 3 and 4) in the anterior compartment appeared to be protective for postoperative
UUI. A previous study has shown that UUI decreased more in case the anterior com-
partment was operated as compared to other compartments.17 The fact that a higher
preoperative POP stage in the anterior compartment is a protective factor, however, is
new information from the present study.
The findings that anatomical recurrence in the anterior compartment protects women
for SUI postoperatively may be explained by the fact that, recurrent, anterior compart-
ment prolapse can mask an existing SUI due to urethral kinking.
In contrast with some previous studies, we could not identify hysterectomy as an
independent risk factor for SUI or UUI.18−21 These previous studies, however, has not
taken into account all the risk factors of the present study.
The use of mesh in POP surgery was not an independent risk factor neither for SUI,
nor UUI. These results differ from earlier studies which have reported an incidence of
25% de novo SUI after POP surgery with the use of mesh.22,23 Hiltunen et al. reported
a significantly higher incidence of postoperative SUI after anterior colporrhaphy with
a tailored mesh as compared without.24 However Ek et al. have found a significant
improvement of UUI and no difference in SUI after POP surgery with the use of mesh as
compared with native tissue repair.25 Also Withagen et al. found no difference in de
novo SUI between native tissue repair and vaginal mesh repair.26 The literature is not
conclusive yet about mesh as a potential risk factor for UI. In this study we could not
demonstrate any association between the use of mesh and the presence of UUI or SUI
postoperatively.
The fact that a high BMI was identified as risk factor for SUI postoperatively is
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consistent with an earlier report.19 The presence of COPD is an established risk factor
for the presence of SUI and was confirmed in the present study as well.27
Strengths of this study are the large sample size, which enables multivariable analysis
and the assessment of risk factors for postoperative UI, the use of validated instruments
of measurement and adequate length of follow up. A limitation of this study could be
that we included many different surgical techniques. Although as shown in the analysis,
the specific compartment of the surgery or the use of mesh did not appear to be a risk
factor or protective for post-operative urinary incontinence. By including all prolapse
surgery, and not for instance only the anterior compartment, the outcome of the study
becomes more clinically relevant for day to day practice. Another limitation was that we
do not test for the presence of masked SUI. On the basis of this study it can therefore
not be stated that testing for masked SUI gives better or worse results than not testing.5
The conclusions of this study may be limited due to the selected population of a tertiary
referral center with a high number of complex and recurrent surgeries.
To summarize, this study showed that the presence of preoperative SUI or UUI was
the most important predictor of SUI and UUI postoperatively. Furthermore, BMI and
COPD were identified as important risk factors for SUI. Use of transvaginal mesh had
no effect on the presence of SUI and UUI postoperatively. De novo SUI appeared in 22%,
de novo UUI appeared in 21% of women. On the other hand however, approximately
40% of women with symptoms of UUI or SUI were cured by POP surgery alone.
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General discussion
General discussion
In this thesis various aspects of repair of Pelvic Organ Prolapse (POP) with emphasis
on the anterior compartment were evaluated. This thesis thereby provides insight in the
technique of the anterior colporrhaphy, the opinion of gynaecologists, the use of mesh
in pelvic organ prolapse and the changes in urinary incontinence rates after surgery
for pelvic organ prolapse. In this chapter we have summarized our main results and
discussed the findings and its clinical implications.
History and technique of surgery of the anterior
compartment
For over 200 years, there have been published on surgery of the prolapsed anterior vaginal
wall. Many modifications have been introduced since long-term outcomes of anterior
colporrhaphy have never been satisfying. All modifications have not lead to a perfect
surgical result and today we are still searching for the best approach for an anterior
vaginal wall prolapse. The first surgical repair for the prolapsing anterior vaginal wall
was described in the beginning of the 19 th century (Chapter 2).1,2 Abdominal approach
and interposition operations (transposition of the uterus and bladder) are examples of
important operations which were applied in the 19 th and 20 th century.3−5 In the course
of the 20 th century the anterior colporrhaphy became more important in the treatment
of the anterior vaginal wall prolapse, but recurrence rates were still unacceptably high
and vaginal mesh was introduced to improve these recurrence rates. Although the use
of modern light weight non-absorbable mesh looked promising with regard to efficacy,
the side effects (graft exposure, pain and shrinkage) are still an issue of major concern.
New developments are expected from basic research with e.g. stemcells or other forms of
tissue engineering. With prevention of POP still in its infancy we will have to continue
to search for the best therapy for this long standing and historical problem (Chapter 2).
Contemporary approaches of anterior colporraphy
A number of recent Dutch studies have shown comparable but poor anatomical outcome
of anterior colporrhaphy. Evaluation of the variation in techniques of anterior colporraphy
among members of the Dutch Urogynaecologic Society was performed to get more insight
in the variation of techniques and potentially find a reason for the high recurrence rates
(Chapter 3).6,7 Our findings have demonstrated that gynaecologists use a wide variety of
surgical techniques to treat a cystocele. This suggests that there is no clear consensus
with regard to the best surgical procedure. The wide variation in techniques may be
a consequence of the lack of evidence as to what the best practice is. It is unknown
which part of the procedure (diagnosis, preoperative, perioperative, or postoperative care)
contributes the most to surgical failure. Our study has shown that there is little difference
with regard to use of a vaginal packing, duration of catheterization, or the day of its
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removal. Factors such as length of incision, suturing techniques, and suture material were
similar and unlikely to have a great impact on recurrence rates. Potentially important
with regard to the explanation for the high recurrence rates, maybe differentiation
between central and lateral defects or the way of dissecting the vaginal wall. Only one
other similar study was found in the literature, however with a low response rate.8 In
that study, members of the AUGS reported a comparable high variation in techniques.
Approximately half of the gynaecologists in the Netherlands attempt to dissect the
vaginal wall from the underlying tissue as thin as possible. The other half considered
thinness less important and dissects in the most optimal surgical plane. Theoretically
this is an important technical issue, but we did not study the effects. There are no
comparative studies between the two techniques, so we decided to compare the difference
in histological thickness of the removed anterior vaginal wall between different surgical
dissecting techniques of anterior colporrhaphy (Chapter 4). The study showed that there
was no significant difference in histology between the ”thin as possible” and ”optimal
surgical plane” techniques. However, we found a significant difference in the epithelial
and muscular layer thickness whether or not hydrodissection was used. This might be
explained by the fact that the injection of fluid makes the underlying tissue thicker. The
lack of difference in the thickness of the removed tissue between ”thin as possible” and
”optimal surgical plane” implies that this is unlikely to explain a clinical relevant difference
in technique and effectiveness. Overlooking the problem of the surgical correction of a
cystocele it is clear that there exist many variations in technique without any evidence
that one variation is superior to the other which is also clearly the case in the whole
field of surgery for POP. Besides it is not unlikely that the “ideal” operation exists
for all patients. To know however which variety or technique would fit a particular
patient best is extremely difficult to study since so many variables between patients
exists necessitating very large studies . However ideally we should try to reach a form
of ’personalized’ surgery. Research in medical and human genetics could enable a more
detailed understanding of the impact of genetics in pelvic organ prolapse. New imaging
techniques such as dynamic MRI would be able to ensure a more personal approach for
better results after surgery for pelvic organ prolapse.
Mesh in pelvic organ prolapse
Since vaginal mesh surgery is controversial, the use of synthetic vaginal meshes was
evaluated among Dutch (uro)gynaecologists for the surgical repair of POP in 2010
(Chapter 5). This study has shown that almost three quarters of the urogynaecologists
in the Netherlands use synthetic grafts in vaginal prolapse surgery, but the overall use
of synthetic mesh in vaginal POP surgery is low (14.4%). Most urogynaecologists use
synthetic grafts only in recurrent repair and not in primary surgery. In the study of
members of the AUGS, Shippey et al. reported that 44% of the responding AUGS
members used synthetic mesh in primary cystocele repair and 42% used synthetic mesh
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in repair of a recurrent cystocele.8 One unanticipated finding in that study was that
general obstetrician/gynaecologists used synthetic mesh more often than the fellowship
trained urogynaecologists (61% vs. 40%; p = 0.005). A similar comparison was found
regarding approach of recurrent cystocele repair (53% vs. 37%; p = 0.022). Shippey et
al. suggested that respondents after a completed fellowship had a more cautious attitude
while awaiting data to document the safety and efficacy of meshes. Compared with
our findings, use of synthetic mesh in the Netherlands was higher (71%). The Dutch
urogynaecologists used synthetic mesh mainly in repair of a recurrent prolapse (72%).
A possible explanation for the difference with the American study was that the Dutch
survey was performed three years later. The overall use of synthetic mesh had increased
over those years.
In October 2008, the United States FDA issued a notification regarding complications
associated with surgical mesh devices for repair of POP or stress urinary incontinence.9
The FDA formulated several recommendations that should be taken into consideration
before using mesh. In July 2011, a much more critical update was provided on more
serious complications associated with surgical mesh for transvaginal repair of POP.10
In July 2012 the manufacturer of Prolift® (Ethicon Women’s Health and Urology,
Somerville, NJ) and Prolift+M® (Ethicon Women’s Health and Urology, Somerville, NJ)
decided to withdraw both products from the market for ’commercial’ reasons. The newer
partially absorbable mesh had been developed to reduce adverse side effects that had been
reported with non absorbable meshes such as exposure, pain and shrinkage. In our study
comparing trocar guided vaginal non-absorbable mesh repair (Prolift®) with trocar
guided partially absorbable mesh repair (Prolift+M®) in pelvic organ prolapse surgery
the success rates were equal (Chapter 6). In the untreated compartment, the risk of re-
operation for POP was higher when using non-absorbable mesh. An explanation could be
that a stiffer non-absorbable mesh increases the risk of de novo prolapse in the untreated
compartment. This could also explain the significant difference in re-surgery between
non-absorbable and partially absorbable mesh (6% vs. 1%, P=0.002), in particular of the
untreated compartment. Mesh exposure rates were higher in the non-absorbable mesh
group compared to the partially absorbable mesh group (12% vs 5%, P<0.001). A likely
explanation for the lower exposure rate in the partially absorbable mesh group is that
the partially absorbable vaginal mesh system is lighter after absorption and initiates a
lesser inflammatory response. The high mesh exposure rates after use of non-absorbable
mesh systems was one of the reasons to search for improvement. Recently, a study
that compared a lightweight versus a heavier-weight mesh demonstrated a similar (not
statistically significant) difference in mesh exposure rate in favour of the light weight
mesh.11 The conclusion of our study was that the results of the partially absorbable mesh
were better than the non-absorbable mesh. Whether this is due to the mesh properties
or the increased experience of the surgeons is not yet clear. It is unfortunate that despite
the favourable results of the partially absorbable mesh, the manufacturer has decided
to withdraw the product from the market (for commercial reasons). Patients with a
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recurrent prolapse have to rely again on old-fashioned manners to operate a recurrence,
an anterior or posterior colporrhaphy, a method with again a high recurrence rate.
Urinary incontinence after surgery for pelvic organ
prolapse
Loss of support of the anterior vaginal wall or apical compartment may affect bladder
and/or urethral function. Symptoms of stress urinary incontinence (SUI) often coexist
with stage 1 or 2 prolapse.12,13 Therefore we focused on the changes in urinary incontinence
(UI) rates pre- and postoperatively and identified risk factors that predict the presence
of symptoms of urgency urinary incontinence (UUI) or stress urinary incontinence (SUI)
after surgery for pelvic organ prolapse (POP) without concomitant or previous anti-
incontinence surgery (Chapter 7). In this large prospective cohort study, we have shown
trends in UI after POP surgery in which not only cure of incontinence and de novo
incontinence was studied but also improvement and deterioration of existing incontinence.
A number of patients developed de novo SUI (22%) and a similar number developed de
novo UUI (21%) after POP surgery. These results are consistent with previous studies.14
Patients without SUI or UUI preoperatively should thus be counselled on the risk of
developing de novo SUI or UUI. On the other hand, 39% of the women with a pre-existing
SUI were (subjectively) cured by POP surgery alone. Forty-two per cent were cured of
pre-existing UUI without concomitant anti-incontinence surgery. We therefore consider
it reasonable to be cautious with performing concomitant anti-incontinence surgery and
first await the effects of POP surgery alone. This finding is in agreement with Borstad’s
findings that showed that 27% of women were cured of SUI by POP surgery alone.15
Our study demonstrated that pre-existing UI (SUI and/or UUI) was an independent risk
factor for UUI after POP surgery. The presence of a high-grade POP (stage 3 and 4) of
the anterior compartment appeared to be protective for postoperative UUI. A previous
study has shown that UUI decreased more in case the anterior compartment was operated
as compared to other compartments.16 BMI and COPD were identified as important risk
factors for SUI postoperatively. Use of transvaginal mesh had no additional effect on the
presence of SUI and UUI postoperatively. This study is interesting for many practising
gynaecologists. Surgery for pelvic organ prolapse is now often combined with surgery for
urinary incontinence. This study shows that it possibly might be better to wait with
concomitant anti-incontinence surgery and first await the effect of POP surgery alone.
Since the combination of both complaints is very common this information is critical
for practising gynaecologists and could have a significant impact on the possibility of
reducing costs.
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Conclusions
Ancient reports of the treatment of anterior vaginal wall prolapse describe a wide range
of techniques to repair the prolapsed anterior vaginal wall. At present we still have a
high rate of recurrence after anterior colporraphy. This seems to indicate that the ideal
technique has not been identified yet. The use of vaginal mesh was promising but side
effects are major concern (Chapter 2).
Dutch gynaecologists use a variety of surgical techniques in their operations of a cysto-
cele. There is no widely accepted concensus on the best surgical approach (Chapter 3).
Dissecting the vaginal wall as thin as possible in an anterior colporrhaphy does not
result in a histologically thinner removed vaginal layer than dissecting in the most
optimal surgical plane. The use of hydrodissection results in a thicker trimmed tissue,
the thickness of the lamina propria layer was remarkably consistent in all specimens.
(Chapter 4).
Vaginal mesh use for pelvic organ prolapse repair surgery is common practice in the
Netherlands but at a fairly low frequency per practice. The most prominent indication
is repair of recurrent prolapse (Chapter 5).
Non-absorbable and partially absorbable mesh achieves similar anatomical outcomes
at 12 months. The risk of reoperations is lower when using partially absorbable mesh.
Mesh exposures are less frequently seen in the partially absorbable mesh group compared
to the non-absorbable mesh group (Chapter 6).
De novo stress urinary incontinence and de novo urgency urinary incontinence appeared
in 22%, respectively 21% of women after surgery for pelvic organ prolapse. Approximately
40% of women with symptoms of stress or urgency urinary incontinence were cured by
POP surgery alone (Chapter 7).
Preoperative stress or urgency urinary incontinence is the most important predictor of
stress or urgency urinary incontinence postoperatively. BMI and COPD were identified
as important risk factors for stress urinary incontinence. Use of transvaginal mesh
had no additional effect on the presence of stress and urgency urinary incontinence
postoperatively (Chapter 7).
Topics for future research
On the basis of this thesis the following topics for future research are suggested.
• To study the implementation and effects of the recently developed Dutch protocol
on vaginal mesh surgery amongst Dutch (uro)gynaecologists.
• Prospective studies which investigate the differences in techniques of the anterior
colporrhaphy with special attention to the differentiation between central and
lateral defects.
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• Studies on the long term results of the use of mesh in POP surgery and comparing
different types of mesh.
• Randomized controlled trials with adequate follow up which investigate the re-
lationship between surgical technique and anatomical outcome after anterior
colporrhaphy.
• To study new and innovative ways of improving vaginal surgery with or without
the use of synthetic materials
• To study the role of abdominal and vaginal POP surgery.
• Develop national databases (linked with electronic medical record) with pre-and
postoperative data (e.g. POP-Q score, medical history, complications and co-
morbidity) of every patient who underwent surgery for pelvic organ prolapse.
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Summary
Summary
Chapter 1
This Chapter provides a general introduction on the subject of pelvic organ prolapse
(POP). Pelvic organ prolapse occurs when the female pelvic organs descent from their
normal position, into or through the vagina. This happens, in particular, with the uterus,
bladder and rectum. When the bladder prolapses, this is called a cystocele, the anterior
vaginal wall can be seen with physical examination. Around 50% of the parous women
lose pelvic floor support, resulting in prolapse, however only a minority of these women
are bothered by this condition. The pathophysiology of pelvic organ prolapse is believed
to be multifactorial. Many risk factors for pelvic organ prolapse have been suggested,
but the most important are vaginal childbirth, advancing age and obesity. The most
common symptom of prolapse is a sensation of pelvic pressure/heaviness or protrusion
of tissue from the vagina. There are several manners to treat pelvic organ prolapse.
They can be divided into two options; non-surgical and surgical. Non-surgical treatment
options are pessaries and pelvic floor excercises. Surgical treatment may be necessary if
non-surgical options are not desired, fail or in case of severe prolapse. The most frequent
approach for correction of an anterior vaginal wall prolapse is the anterior colporrhaphy.
Unfortunately recurrence after this operation is high. This thesis attempts to provide
insight into the effectiveness of surgery for POP with emphasis on anterior vaginal wall
surgery.
Chapter 2
In Chapter 2 we provides a detailed historical review of the surgical treatment of pelvic
organ prolapse in which we specifically focused on the anterior compartment. Probably
the first explanation of the treatment of pelvic organ prolapse dates from 1500 B.C. The
Egyptians gave a description to ’falling of the womb’ in the Kayun papyrus. Over a
millenium later, Euryphon, a contemporary of Hippocrates (400 B.C.) described some
interesting therapeutic options, from succusion (turning a women upside down for several
minutes) to irrigation the displaced uterus with wine. A wide range of techniques have
been attempted to repair the prolapsing anterior vaginal wall. By 1866, J.M. Simm
had already performed a series of operations very similar to a modern anterior repair.
George White in 1909 published on his frustration with the suboptimal outcome of
operations for the repair of a cystocele. He believed that the practice of removing part
of the anterior wall before suturing the cut ends together was irrational and destined for
failure. Interposition operations in which the uterus was positioned between the bladder
and the vaginal wall were popular in the end of the nineteenth century. In 1890, were
the first reviews about the abdominal approach of cystocele. In the twentieth century
several modifications of the abdominal approach were made, but this is now little used
because it is a high risk of complications. The first description of using mesh in the
repair of cystoceles was the use of tantalum mesh in 1955. In 1970, the first report of
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collagen mesh in the urogynaecology was described. The use of non-absorbable mesh and
xenogenous tissues started around the beginning of the nineties Nowadays the robotic
assisted surgery and cell based tissue engineering are the latest inventions.
Chapter 3
In Chapter 3 we evaluate the variation in techniques of anterior colporrhaphy among
members of the Dutch Urogynaecologic Society. A questionnaire evaluating the technique
of anterior colporrhaphy, preoperative and postoperative care and use of the POP-Q
score was sent out by e-mail. One hundred and thirty-three questionnaires were analysed
(respone rate 65%). There are large variations in incisions, use of hydrodissection, method
of plication, and excision of redundant vaginal epithelium. The urinary catheter was
generally removed on day 2 after surgery and the vaginal pack on day 1. Three-quarters
of the participants (77%) responded that they use the POP-Q, of whom only 52% use
it routinely. This study showed that Dutch gynaecologists use a variety of surgical
techniques to operate on a cystocele. This suggests that there is no widely accepted
opinion on the best surgical approach. The lack of differentiation between central and
lateral defects is striking and in contrast with the, mostly, American literature.
Chapter 4
This Chapter provides an evaluation of the difference in thickness of the removed anterior
vaginal wall between different surgical dissecting techniques of anterior colporrhaphy. In
patients undergoing primary anterior colporrhaphy, trimmed vaginal tissue was taken
from different surgical techniques of vaginal wall dissection. Tissue was preserved in
formalin and stained with hematoxylin-eosin and Elastica von Giesen. The examiner
was an experienced pathologist blinded for the surgical technique. The specimens were
examined for the epithelial thickness (ET), lamina propria thickness (LPT), muscular
layer thickness (MT) and total thickness (TT). Tissue from the anterior vaginal wall was
analysed in 93 women who underwent anterior compartment pelvic organ prolapse surgery.
There was no difference in thickness measured in the 3 histological layers and for the total
thickness between the different surgical techniques. The use of hydrodissection was the
only independent factor leading to a thicker removed vaginal tissue. We conclude that
dissecting the vaginal wall as thin as possible does not result in a thinner removed vaginal
layer than dissecting in the most optimal surgical plane. The use of hydrodissection
provides a thicker trimmed tissue.
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Chapter 5
In Chapter 5, the results of an evaluation of the use of mesh in vaginal prolapse surgery
amongst members of the Dutch Urogynaecologic Society are described. A questionnaire
evaluating the use of mesh vs. native tissue repair in vaginal prolapse surgery was sent
out by email to all members. Some specific questions on standard measures of infection
prevention were included. One hundred and thirty-three completed questionnaires were
received (response rate was 65%). Seventy-one percent of respondents stated that
they apply use synthetic meshes in their patients. The mean percentage of mesh use
in all vaginal pelvic organ prolapse surgery was 14%. Most responders use mesh in
recurrent surgery only. Prolift® is the most commonly used brand. All women received
prophylactic antibiotics. Although only half of the respondents changed gloves during
the operation, before inserting the vaginal mesh.
Chapter 6
In Chapter 6 we compared failure rates and complications in patients undergoing trocar
guided vaginal mesh repair (Prolift®) with trocar guided partially absorbable mesh
(Prolift+M®) repair in pelvic organ prolapse surgery. Consecutive women undergoing
non-absorbable or partially absorbable mesh for symptomatic stage 2 or greater vaginal
prolapse were prospectively evaluated at 12 months. Outcome measures included objective
and subjective failure rates, patient’s satisfaction, complications and perioperative
outcomes. Five hundred forty-nine women (non-absorbable mesh 327, partially absorbable
mesh 222) were included in the study. Failure rates were similar in both groups; re-surgery
in the untreated compartment was higher in the non-absorbable mesh group compared
to the partially absorbable mesh group (5% vs 1%). Mesh exposure rate was 12% in
the non-absorbable mesh group and 5% in the partially absorbable mesh group. Other
complications and patient satisfaction were similar in both groups.
Chapter 7
In this Chapter we focused on the changes in urinary incontinence (UI) rates pre- and
postoperatively and identified risk factors which predict the presence of symptoms of
urgency urinary incontinence (UUI) or stress urinary incontinence (SUI) after surgery
for pelvic organ prolapse (POP). All consecutive women (907) who underwent POP
surgery without concomitant or previous anti-incontinence surgery in the years 2004-2010
were included. Assessments were performed preoperatively and at 1-year follow-up,
including pelvic organ prolapse quantification score and a standardized urogynaecological
questionnaire (Urogenital Distress Inventory, UDI). Primary outcome of this study
was stress and/or urgency UI postoperatively. Furthermore, this study measured the
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improvement or worsening of UI following surgery using the UDI. Univariable- and
multivariable logistic regression with forward selection procedure was used to identify
the risk factors. De novo SUI appeared in 22% and de novo UUI occurred in 21% of
the women. At 1-year 42% were cured for UUI and 39% were recovered from SUI by
POP surgery alone. The best predictor for the occurrence of postoperative SUI or UUI
was the presence of preoperative SUI or UUI. BMI and chronic obstructive pulmonary
disease (COPD) were identified as independent risk factors for postoperative SUI. A
recurrence in the anterior compartment protected against SUI postoperatively.
Chapter 8
Chapter 8 is a general discussion on the findings of this thesis. Furthermore the general
conclusions of this thesis are presented and some challenging aspects of future research
are suggested to improve the treatment of pelvic organ prolapse, especially the anterior
compartment.
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Hoofdstuk 1
Dit hoofdstuk geeft een algemene inleiding over het onderwerp genitale prolaps. Genitale
prolaps ontstaat wanneer de vrouwelijke bekkenorganen verzakken naar of via de vagina.
Dit gebeurt met name met de baarmoeder, blaas en rectum. Wanneer een blaas verzakt,
een cystocele genaamd, kan de voorste vaginawand zichtbaar worden bij lichamelijk
onderzoek. Bij ongeveer 50% van de vrouwen die ooit bevallen zijn kan overrekking of
scheuring van bindweefsel optreden, wat tot genitale prolaps kan leiden, echter alleen
een minderheid van de vrouwen heeft klachten van deze prolaps. De etiologie van
prolaps is multifactorieel. Veel risicofactoren voor genitale prolaps zijn bekend; de
meest belangrijke zijn een vaginale bevalling, oudere leeftijd en obesitas. De meest
voorkomende symptomen van een genitale prolaps zijn balgevoel of drukkend gevoel in
de vagina. Er zijn verschillende manieren om een prolaps te behandelen. Ze kunnen
worden onderverdeeld in 2 groepen; niet-chirurgisch (conservatief) en chirurgisch. Niet-
chirurgische behandelingen bestaan uit pessaria en bekkenfysiotherapie. Chirurgisch
ingrijpen kan noodzakelijk zijn als niet-chirurgische behandelingen niet afdoende helpen
of in het geval van een ernstige prolaps. De meest gebruikte chirurgische aanpak van
een verzakking in het voorste compartiment is de voorwandplastiek. Helaas zijn de
recidiefpercentages na deze operatie hoog. Dit proefschrift probeert inzicht te geven
in de historie, de techniek en de effectiviteit van prolaps-chirurgie met nadruk op het
voorste compartiment.
Hoofdstuk 2
In hoofdstuk 2 wordt een gedetailleerd historisch overzicht gegeven van de chirurgische
behandeling van een prolaps, waarin specifiek aandacht wordt gegeven aan het voorste
compartiment. Vermoedelijk werd de eerste uitleg van een behandeling voor prolaps
gegeven in 1500 voor Christus. De Egyptenaren gaven reeds een beschrijving van
’het vallen van de baarmoeder’ in de Kahun papyrus. Meer dan een millenium later
beschreef Euryphon, een tijdgenoot van Hippocrates (400 BC), een aantal interessante
therapeutische mogelijkheden, zoals ”succusion”(het gedurende enkele minuten op haar
hoofd draaien van een vrouw) en irrigatie van de baarmoeder met wijn. Er zijn vele
technieken uitgeprobeerd om een prolaps van het voorste compartiment te herstellen.
In 1866 presenteerde J.M. Sim al een operatie die zeer vergelijkbaar is met de moderne
voorwandplastiek. George White publiceerde in 1909 een artikel over zijn frustratie over
de slechte uitkomsten van de chirurgische behandeling van een cystocele. Hij geloofde
dat het verwijderen van een deel van de voorwand en het weer hechten irrationeel was
en gedoemd was te mislukken. Operaties waarbij de baarmoeder verplaatst werd tussen
de blaas en de vaginawand waren populair in het einde van de negentiende eeuw. In
1890 zijn de eerste reviews over de abdominale aanpak van cystocele gepubliceerd. In
de twintigste eeuw werden nog verscheidene wijzigingen in de abdominale benadering
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aangebracht, maar deze techniek wordt nu nauwelijks meer gebruikt vanwege het hoge
risico op complicaties. In de eerste beschrijving van het gebruik van mesh voor de
operatie van een cystocele werd een tantalium mesh gebruikt (1955). In 1970 werd het
eerste onderzoek over de toepassing van collageen mesh in de urogynaecologie beschreven.
Het gebruik van niet-absorbeerbare mesh en xenogene weefsels begon rond het begin van
de jaren negentig. Tegenwoordig zijn robot geassisteerde chirurgie en het gebruik van
stamcellen de nieuwste uitvindingen.
Hoofdstuk 3
In hoofdstuk 3 evalueren we de variatie van de techniek van een voorwandplastiek
onder leden van de Werkgroep Bekkenbodem van de NVOG. Een vragenlijst over de
techniek van de voorwandplastiek, pre-en postoperatieve zorg en het gebruik van de
POP-Q score werd verstuurd via e-mail. Honderddriee¨ndertig vragenlijsten werden
geanalyseerd (respons percentage 65%). Er bleken grote verschillen in gebruikte incisies,
het gebruik van hydrodissectie, de wijze van pliceren en de eventuele excisie van overtollig
vaginaepitheel. De urinekatheter werd algemeen verwijderd op dag 2 na de operatie en
de tampon op dag 1. Driekwart van de deelnemers (77%) antwoordde dat zij de POP-Q
gebruikt, van wie slechts 52% routinematig. Deze studie toont aan dat Nederlandse
gynaecologen verschillende chirurgische technieken voor een voorwandplastiek gebruiken.
Dit suggereert dat er geen algemeen aanvaarde opvatting is over de beste chirurgische
benadering. In tegenstelling tot de meestal Amerikaanse literatuur valt op dat de
Nederlandse gynaecoloog geen onderscheid maakt tussen centrale en laterale defecten.
Hoofdstuk 4
Dit hoofdstuk geeft een evaluatie over het verschil in dikte van de verwijderde voorste
vaginawand tussen het zo dun mogelijk afprepareren of het prepareren in het optimale
chirurgische vlak bij een voorwandplastiek. Bij patie¨nten die een primaire voorwandplas-
tiek ondergingen werd weefsel verzameld wat werd verwijderd bij het trimmen van de
vaginawanden. Er was sprake van 4 verschillende dissectiemethoden, door 4 verschillende
chirurgen; naast dun versus ”optimaala¨fprepareren werd ook gekeken naar het gebruik
van hydrodissectie. Weefsel werd bewaard in formaline en gekleurd met hematoxyline-
eosine en Elastica von Giesen. De onderzoeker was een ervaren patholoog geblindeerd
voor de chirurgische techniek. De monsters werden onderzocht op de epitheliale dikte
(ET), lamina propria dikte (LPT), spier laagdikte (MT) en de totale dikte (TT). Weef-
sels werden geanalyseerd bij 93 vrouwen bij wie een voorwandplastiek was uitgevoerd.
Er was geen verschil in dikte tussen de verschillende chirurgische technieken in de 3
histologische lagen en de totale dikte. Het gebruik van hydrodissectie bleek de enige
onafhankelijke factor die leidt tot een dikker afgeprepareerde laag. We concluderen dat
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het zo dun mogelijk afprepareren van de vaginawand niet tot een dunnere laag leidt dan
het afprepareren in het meest optimale chirurgische vlak.
Hoofdstuk 5
In hoofdstuk 5 worden de resultaten beschreven van een evaluatie van het gebruik van
mesh in prolapschirurgie onder leden van de werkgroep bekkenbodem van de NVOG. Een
vragenlijst over het gebruik van mesh versus conventionele vaginale prolaps plastiek werd
verstuurd via een e-mail naar alle leden. Honderddriee¨ndertig ingevulde vragenlijsten
werden ontvangen (respons percentage 65%). Eenenzeventig procent van de respondenten
verklaarde dat zij synthetische mesh gebruikte bij hun patie¨nten. Het gemiddelde
percentage van mesh gebruik in alle vaginale prolapsoperaties was 14%. De meeste
gynaecologen gebruiken mesh alleen bij operaties voor een recidief. Prolift® is het meest
gebruikte merk. Alle vrouwen kregen profylactisch antibiotica. Slechts de helft van de
respondenten wisselde handschoenen tijdens de operatie, alvorens de vaginale mesh te
impanteren.
Hoofdstuk 6
In hoofdstuk 6 hebben we het falen, zowel in anatomische als in functionele zin, en
complicaties vergeleken tussen patie¨nten die een prolaps operatie ondergingen met
trocar geleide vaginale mesh (Prolift®) of trocar geleide gedeeltelijk resorbeerbare
mesh (Prolift+M®). Vrouwen die een niet-resorbeerbare of gedeeltelijk resorbeerbare
mesh kregen voor een symptomatische prolaps stadium 2 of hoger werden prospectief
gee¨valueerd na 12 maanden. De uitkomstmaten waren objectief en subjectief falen, patie¨nt
tevredenheid, complicaties en perioperatieve uitkomsten. Vijfhonderdnegenenveertig
vrouwen (niet resorbeerbare mesh 327, gedeeltelijk absorbeerbare mesh 222) werden
in de studie opgenomen. Falen was vergelijkbaar in beide groepen, re-operatie in het
onbehandelde compartiment was hoger in de niet-absorbeerbare mesh groep vergeleken
met de gedeeltelijk resorbeerbare mesh groep (5% vs 1%). Mesh exposure (het zichtbaar
worden van een stukje van de mesh door de vagina) werd gezien in 12% in de niet-
absorbeerbare mesh-groep en 5% in de gedeeltelijk absorbeerbare mesh groep. Overige
complicaties en patie¨nt tevredenheid waren vergelijkbaar in beide groepen.
Hoofdstuk 7
In dit hoofdstuk hebben we ons gericht op veranderingen in urine incontinentie na een
prolaps operatie. Daarnaast werden ook risicofactoren geidentificeerd die een verhoogd
risico geven op postoperatieve stress of urge urine incontinentie. Vragenlijsten werden
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preoperatief en na 1-jaar follow-up afgenomen, inclusief POP-Q score waarbij met name
de gestandaardiseerde urogynaecologische vragenlijst (UDI) werd gebruikt. Primaire
uitkomst van deze studie was stress en/of urge urine incontinentie postoperatief. Verder
werd, naast aan- of afwezigheid van incontinentie, ook gekeken naar een verbetering of
verslechtering van de urine incontinentie na de prolapsoperatie met behulp van de UDI.
Univariabele en multivariabele logistische regressie met voorwaartse selectie procedure
werd gebruikt om de risicofactoren te kunnen identificeren. De novo stress incontinentie
trad bij 22% van de geopereerde vrouwen op, de novo urge incontinentie bij 21%. Na
1 jaar waren 42% van de vrouwen met urge incontinentie en 39% van de vrouwen met
stress incontinentie genezen van hun incontinentie door middel van de prolaps operatie
alleen. De beste voorspeller voor het optreden van postoperatieve stress of urge urine
incontinentie was de aanwezigheid van pre-operatieve stress of urge urine incontinentie.
Daarnaast werden obesitas en chronische obstructieve longziekte (COPD) aangemerkt
als onafhankelijke risicofactoren voor postoperatieve stress incontinentie. Postoperatieve
stress incontinentie kwam minder vaak voor als vrouwen na 1 jaar een recidief hadden in
het anterieure compartiment.
Hoofdstuk 8
Hoofdstuk 8 is een algemene discussie over de bevindingen van dit proefschrift. Verder
worden de algemene conclusies van dit proefschrift gepresenteerd en worden er een aantal
uitdagende mogelijkheden voor toekomstig onderzoek voorgesteld om de behandeling
van een prolaps te verbeteren, met name die van het voorste compartiment.
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AAbbreviations
AUGS American Urogynecologic Society
BMI Body Mass Index
COPD Chonic Obstructive Pulmonary Disease
CI Confidence Interval
ET Epithelial Thickness
FDA Food and Drug Administration
HRT Hormone Replacement Therapy
IUGA International Urogynecological Association
LPT Lamina Propria Thickness
MT Muscular Layer Thickness
NIH National Institutes of Health
OR Odds Ratio
PGI-I Patients’ Global Impression of Improvement
POP Pelvic Organ Prolapse
POP-Q Pelvic Organ Prolapse Quantification
SUI Stress Urinary Incontinence
UDI Urogenital Distress Inventory
UI Urinary Incontinence
UUI Urgency Urinary Incontinence
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Instructie. 
 
Geachte mevrouw, 
 
Voor u ligt de vragenlijst die u hebt ontvangen van uw behandelende gynaecoloog. 
De vragenlijst is bedoeld om meer inzicht te krijgen in uw problematiek en om het 
effect van de voorgestelde behandeling te kunnen meten. In Nederland wordt het 
gebruik van deze vragenlijst aanbevolen door de Werkgroep Bekkenbodem van de 
Nederlandse Vereniging voor Obstetrie en Gynaecologie. De vragenlijst bestaat uit 
een aantal onderdelen. Deze onderdelen bevatten soms vragen waarvan u 
misschien denkt dat ze niet van belang zijn. Wij verzoeken u echter wel om alle 
vragen in te vullen tenzij anders vermeld. Het invullen duurt ongeveer 10 minuten 
 
 
 
 
 
 
Naam: 
 
Geboortedatum: 
 
 
 
 
Lengte: 
 
Gewicht: 
 
 
 
 
Datum van invullen:
 1
 2
---------------------------------------------------------------------------------------------------------------- 
Dit deel van de vragenlijst bevat een aantal algemene vragen. Omcirkel het bij u passend 
antwoord of vul het getal in. 
---------------------------------------------------------------------------------------------------------------- 
 
1. Wat is uw leeftijd?         ..................................jaar 
 
 
2. Welke opleiding(en) heeft u voltooid? (meer dan één antwoord mogelijk) 
1 basisonderwijs / lagere school (of een deel daarvan) 
2 lager beroepsonderwijs (lts, lhno, leao, huishoudschool etc.) 
3 mavo, (m)ulo etc. 
4 middelbaar beroepsonderwijs (mts, meao, opleiding tot verpleegkundige etc.) 
5 vwo, havo, gymnasium, mms etc. 
6 hoger beroepsonderwijs (hts, heao, sociale academie etc.) 
7 wetenschappelijk onderwijs (doctoraal examen) 
 
 
3. Wat is uw huidige beroep of zijn uw werkzaamheden? 
.......................................................................................................................................................
....................................................................................................................................................... 
 
 
4. a. Hebt u kinderen? 
  1 Ja   0 Nee (ga door met vraag 5) 
 
b. Hoeveel kinderen heeft u?       .......................... (aantal) 
c. Hebt u een keizersnede gehad?     1 Ja (......keer) 0 Nee  
d. Hebt u een tang verlossing gehad?      1 Ja (......keer) 0 Nee 
e. Hebt u een vacuüm cup verlossing gehad?   1 Ja (......keer) 0 Nee 
f. Bent u tijdens de bevalling “ingeknipt”    1 Ja (......keer) 0 Nee 
g. Bent u tijdens de bevalling “ingescheurd”   1 Ja (......keer) 0 Nee 
h. Wanneer was uw laatste bevalling?   ............................   (dag/maand/jaar) 
e. Hoe oud was u tijdens de eerste bevalling   ……………………(leeftijd in jaren) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ga door met beantwoorden van vraag 5 op de volgende pagina. 
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---------------------------------------------------------------------------------------------------------------- 
Bij de volgende vraag loopt de antwoordcategorieën op van 1 (erg slecht) tot 6 (uitstekend). 
Wilt u het getal omcirkelen dat het meest op u van toepassing is? 
---------------------------------------------------------------------------------------------------------------- 
 
5. Hoe zou u uw algehele kwaliteit van leven gedurende de afgelopen week beoordelen? 
 
1  2  3 4 5  6  
 Erg slecht        uitstekend 
 
---------------------------------------------------------------------------------------------------------------- 
De volgende 5 vragen hebben betrekking op uw huidige gezondheidstoestand. Omcirkel bij 
elke vraag de zin die het best past bij uw eigen gezondheidstoestand vandaag. 
---------------------------------------------------------------------------------------------------------------- 
 
6a. Mobiliteit 
 
1. Ik heb geen problemen met lopen 
2. Ik heb enige problemen met lopen 
3. Ik ben bedlegerig 
 
6b. Zelfzorg 
 
1. Ik heb geen problemen om mijzelf te wassen of aan te kleden 
2. Ik heb enige problemen om mijzelf te wassen of aan te kleden 
3. Ik ben niet in staat mijzelf te wassen of aan te kleden 
 
6c. Dagelijkse activiteiten( bv werk, studie, huishouden, gezin- en vrijetijdsactiviteiten) 
 
1. Ik heb geen problemen met mijn dagelijkse activiteiten 
2. Ik heb enige problemen met mijn dagelijkse activiteiten 
3. Ik ben niet in staat mijn dagelijkse activiteiten uit te voeren 
 
6d. Pijn/klachten 
 
1. Ik heb geen pijn of andere klachten 
2. Ik heb matige pijn of andere klachten 
3. Ik heb zeer ernstige pijn of andere klachten 
 
6e. Stemming 
 
1. Ik ben niet angstig of somber 
2. Ik ben matig angstig of somber 
3. Ik ben erg angstig of somber 
 
 
 
 
 
Best 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Slechtst 
voorstelbare 
gezondheidstoestand
0 
voorstelbare 
gezondheidstoestand6f. 
 
Om mensen te helpen bij het aangeven hoe goed of hoe 
slecht een gezondheidstoestand is, hebben we een 
meetschaal (te vergelijken met een thermometer) 
gemaakt. Op de meetschaal hiernaast betekent “100” 
de beste gezondheidstoestand die u zich kunt 
voorstellen, en “0” de slechtste gezondheidstoestand 
die u zich kunt voorstellen.  
 
We willen u vragen op deze meetschaal aan te geven 
hoe goed of hoe slecht volgens u uw eigen 
gezondheidstoestand vandaag is. Trek een lijn van het 
hokje hieronder naar het punt op de meetschaal dat 
volgens u aangeeft hoe goed of hoe slecht uw 
gezondheidstoestand vandaag is. 
 
 
Uw 
gezondheidstoestand
 
 
vandaag  
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---------------------------------------------------------------------------------------------------------------- 
Vrouwen met ongewenst urineverlies en / of een verzakking hebben aangegeven dat ze de 
volgende klachten hadden. Kunt u aangeven welke klachten u op dit moment ook heeft en 
hoeveel last u daar van heeft. Beantwoord svp alle vragen, ook als u geen klachten heeft. 
---------------------------------------------------------------------------------------------------------------- 
 
 
7.   a. Vindt u dat u vaak moet plassen? 
   1 Ja    2 Nee (ga naar 7c.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
  
c. Hoe veel keer plast u gemiddeld per dag?:      ..……..keer  
  
 
8.  a. Als u moet plassen voelt u dan altijd een sterke aandrang? 
   1 Ja   2 Nee (ga naar 9.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
  
9.  a. Hebt u ongewenst urineverlies als u aandrang voelt om te plassen? 
   1 Ja   2 Nee (ga naar 10.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
 
c. Zo ja, hoe vaak verliest u ongewild urine? 
1. dagelijks 
2. paar keer per week 
3. 1 keer per week 
4. 1 keer per maand 
5. 1 keer per jaar 
  
10. a. Hebt u ongewenst urineverlies bij lichamelijke inspanning, hoesten of niezen? 
    1 Ja   2 Nee (ga naar 11.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
 
c. Zo ja, hoe vaak verliest u ongewild urine? 
1. dagelijks 
2. paar keer per week 
3. 1 keer per week 
4. 1 keer per maand 
5. 1 keer per jaar 
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11. a. Hebt u moeite uw blaas leeg te plassen? 
   1 Ja   2 Nee (ga naar 12.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg  
 
12. a. Hebt u wel eens het gevoel dat de blaas na het plassen niet helemaal leeg is? 
    1 Ja   2 Nee (ga naar 13.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
 
13. a. Hebt u wel eens een drukkend gevoel onder in de buik? 
   1 Ja   2 Nee (ga naar 14.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg  
  
14. a. Hebt u wel eens pijn onder in de buik of in de schaamstreek? 
   1 Ja   2 Nee (ga naar 15.) 
       p 
b. Zo ja, hoeveel last heeft u hier van?  
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
  
15. a. Hebt u wel eens het gevoel dat er iets uit de vagina stulpt? 
   1 Ja   2 Nee (ga naar 16.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg  
 
16. a. Hebt u wel eens gezien dat er iets uit de vagina stulpt?  
   1 Ja   2 Nee (ga naar 17.) 
       p 
b.Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje 3 Nogal     4 Heel erg 
 
17.  Hoe vaak hebt u het afgelopen jaar een blaasontsteking gehad? 
1 Nooit 
2 1 keer 
3 tussen de 2 en 4 keer 
4 meer dan 4 keer 
 
18. a. Moet u ‘s nachts meer dan 1 keer plassen? 
    1 Ja   2 Nee (ga naar 19.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
        1 Helemaal niet  2 Een beetje 3 Nogal     4 Heel erg 
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De navolgende verschijnselen zijn beschreven door vrouwen met klachten van de stoelgang. 
Geeft u aan welke verschijnselen u tegenwoordig herkent en hoeveel last u daarvan heeft.  
---------------------------------------------------------------------------------------------------------------- 
 
19. a. Hebt u minder dan driemaal per week ontlasting? 
   1 Ja  2 Nee (ga naar 20.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg  
 
20. a. Moet u om ontlasting te krijgen in meer dan een kwart van de keren persen? 
   1 Ja  2 Nee (ga naar 21.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg  
 
21. a. Hebt u wel eens aandrang tot ontlasting terwijl er dan op het toilet geen ontlasting 
    komt? 
   1 Ja  2 Nee (ga naar 22.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg 
  
22. a. Hebt u wel eens het gevoel dat er iets uit de anus hangt of er iets voor zit? 
   1 Ja  2 Nee (ga naar 23.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg  
 
23. a. Ervaart u pijn tijdens de aandrang tot ontlasting? 
   1 Ja  2 Nee (ga naar 24.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg  
 
24. a. Ervaart u pijn tijdens of vlak na de ontlasting? 
   1 Ja  2 Nee (ga naar 25.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg  
 
25. a. Verliest u wel eens dunne ontlasting zonder dat u daar controle over heeft? 
   1 Ja  2 Nee (ga naar 26.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg 
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25. c. Hoe vaak komt het voor? 
1. dagelijks 
2. paar keer per week 
3. 1 keer per week 
4. 1 keer per maand 
5. 1 keer per jaar 
 
26. a. Verliest u wel eens vaste ontlasting zonder dat u daar controle over heeft? 
    1 Ja  2 Nee (ga naar 27.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg 
  
 c. Hoe vaak komt het voor?  
1. dagelijks  
2. paar keer per week  
3. 1 keer per week  
4. 1 keer per maand  
     5.   1 keer per jaar 
 
27. a. Verliest u wel eens windjes zonder dat u daar controle over heeft? 
   1 Ja  2 Nee (ga naar 28.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg 
  
 c. Hoe vaak komt het voor?  
1. dagelijks  
2. paar keer per week  
3. 1 keer per week  
4. 1 keer per maand  
     5.   1 keer per jaar 
 
28. a. Moet u wel eens via de schede mee drukken om ontlasting te krijgen? 
    1 Ja  2 Nee (ga naar 29.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg 
 
29.  a. Moet u de ontlasting wel eens met de vingers via de anus verwijderen? 
    1 Ja  2 Nee (ga naar 30.) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
   1 Helemaal niet 2 Een beetje  3 Nogal  4 Heel erg 
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---------------------------------------------------------------------------------------------------------------- 
Sommige vrouwen vinden dat ongewenst urineverlies en/of een verzakking en/of problemen 
met de ontlasting hun activiteiten, relaties en gevoelens kunnen beïnvloeden. De vragen in 
onderstaande lijst gaan over aspecten van uw leven die door uw probleem beïnvloed of 
veranderd kunnen zijn. Geef voor iedere vraag het antwoord aan dat het beste beschrijft hoe 
zeer uw activiteiten, relaties en gevoelens beïnvloed worden door uw urineverlies en/of 
verzakking en/of problemen met de ontlasting. 
---------------------------------------------------------------------------------------------------------------- 
Hoeveel invloed heeft ongewenst urineverlies en/of verzakking en/of problemen met de 
ontlasting gehad op: 
 
30. Uw vermogen om huishoudelijk werk te doen (koken, schoonmaken, wassen)  
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
31. Uw vermogen om klein onderhoud of reparaties te verrichten in en om het huis  
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
32. Boodschappen doen en winkelen 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
33. Reizen met auto of openbaar vervoer over een afstand van minder dan 20 minuten 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
34. Ergens naar toe gaan als u niet helemaal zeker weet of er daar toiletten zijn 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
35. Bezoek krijgen van vrienden en kennissen 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
36. Relaties met vrienden en kennissen 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
37. Vermogen om een seksuele relatie te hebben 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
38. Geestelijke / emotionele gezondheid 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg 
  
39. Wordt u in uw activiteiten beperkt door angst dat anderen u ruiken?      
   1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
Hebt u als gevolg van uw probleem de volgende gevoelens? 
 
40. Nervositeit of ongerustheid  
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
41. Frustratie 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg 
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42.  Zich gegeneerd voelen 
   1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg 
 
 
----------------------------------------------------------------------------------------------------------------- 
De volgende vragen gaan over de seksualiteit. Het is de bedoeling dat u bij het beantwoorden 
denkt aan de situatie van de afgelopen maand. Wilt U het voor u meest passende antwoord 
omcirkelen. 
---------------------------------------------------------------------------------------------------------------- 
  
43.       a. Hebt u wel eens seksueel contact met uw partner? (Denk hierbij aan alle vormen 
van seksueel contact en niet alleen aan geslachtsgemeenschap) 
   1 Ja (beantwoord ook vraag b)   2 Nee (beantwoord ook vraag 43c) 
 
      b. Zo ja, hoe tevreden bent u daarover? 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg 
 
43.      c. Zo nee, hoe vervelend vindt u dat? 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg 
 
44.    Hoe vaak hebt u geslachtsgemeenschap? 
1 Nooit  
2 minder dan 1 keer per maand 
3 1 tot 2 keer per maand 
4 1 keer per week 
5 meerdere keren per week 
 
45.      a. Verliest u wel eens urine tijdens de geslachtsgemeenschap? 
    1 Ja   2 Nee (ga naar 46.) 99 Niet van toepassing (geen seks) 
    p 
 b. Zo ja, hoeveel last heeft u hier van? 
1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg   
 
46.  a. Ervaart u pijn tijdens de geslachtsgemeenschap? 
    1 Ja   2 Nee (ga naar 47.) 99 niet van toepassing (geen seks) 
       p 
b. Zo ja, hoeveel last heeft u hier van? 
     1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg  
 
47.   a. Is de vagina zo nauw dat geslachtsgemeenschap daardoor niet mogelijk is? 
   1 Ja   2 Nee    99 niet van toepassing (geen seks) 
 p 
b. Zo ja, hoeveel last heeft u hier van? 
     1 Helemaal niet  2 Een beetje  3 Nogal 4 Heel erg 
 
 
   Heeft u alle vragen ingevuld?     Hartelijk dank! 
 
©Werkgroep Bekkenbodem 2006 

	  
Deze	  enquête	  is	  bedoeld	  om	  uit	  te	  zoeken	  hoe	  de	  Nederlandse	  
bekkenbodemgynaecoloog	  zijn	  voorwandplastiek	  doet.	  Zoals	  u	  wellicht	  weet	  heeft	  de	  
voorwandplastiek	  een	  hoog	  recidiefpercentage.	  Hoe	  doet	  u	  uw	  voorwandplastiek	  en	  wat	  
is	  uw	  voor-­‐en	  nabeleid?	  
	  
Allereerst	  willen	  we	  u	  wat	  algemene	  vragen	  stellen.	  Alle	  antwoorden	  zijn	  
vanzelfsprekend	  anoniem.	  
	  
1. Wat	  is	  uw	  geslacht?	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   Man 
 	  	  	  	  	   Vrouw 
	  
2. Hoeveel	  jaar	  bent	  u	  gynaecoloog?	  
	   	  	  	  	  	  	  	  
	  
3. Heeft	  u	  de	  bekkenbodem	  als	  subspecialisme?	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   Ja 
 	  	  	  	  	   Nee 
	  
4. Wat	  voor	  type	  kliniek	  bent	  u	  werkzaam?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Perifeer,	  geen	  opleidingskliniek 
	  	  	  	  	   Perifeer,	  opleidingskliniek 
	  	  	  	  	   Universitair 
	  
De	  volgende	  vragen	  zullen	  gaan	  over	  de	  techniek	  van	  de	  voorwandplastiek.	  
	  
Diagnostiek	  en	  voorbereiding	  	  
	  
5. Geeft	  u	  lokale	  of	  systemische	  oestrogenen	  bij	  postmenopauzale	  vrouwen?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Nooit 
	  	  	  	  	   Alleen	  op	  indicatie 
	  	  	  	  	   Meestal 
	  	  	  	  	   Altijd 
	  
6. Maakt	  u	  een	  onderscheid	  tussen	  centrale	  en	  laterale	  defecten?	  
 	  	  	  	  	   Ja 	  	  	  ⇒	  Volgende	  vraag:	  7 
 	  	  	  	  	   Nee 	  	  	  ⇒	  Volgende	  vraag:	  9 
	   	   	   	  
	  
7. Hoe	  maakt	  u	  onderscheid	  in	  centrale	  en	  laterale	  defecten?	  
	   	  	  	  	  	  	  	  
	  
8. Hoe	  past	  u	  hierbij	  uw	  operatie	  aan?	  
	   	  	  	  	  	  	  	  
	  
Antibiotica	  profylaxe	  
	  
9. Geeft	  u	  standaard	  antibiotica	  profylaxe	  bij	  een	  voorwandplastiek?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Ja 
	  	  	  	  	   Nee 
	  
Incisie	  
	  
10. Gebruikt	  u	  hydrodissectie	  bij	  de	  voorwandplastiek?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Nooit 	  	  	  ⇒	  Volgende	  vraag:	  12 
	  	  	  	  	   Alleen	  op	  indicatie 	  	  	  ⇒	  Volgende	  vraag:	  11 
	  	  	  	  	   Meestal 	  	  	  ⇒	  Volgende	  vraag:	  11 
	  	  	  	  	   Altijd 	  	  	  ⇒	  Volgende	  vraag:	  11 
	  
11. Wat	  gebruikt	  u	  voor	  de	  hydrodissectie?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Fysiologisch	  zout 
	  	  	  	  	   Fysiologisch	  zout	  met	  adrenaline 
	  	  	  	  	   Locaal	  anestheticum	  (bijv	  lidocaine) 
	  	  	  	  	   Locaal	  anestheticum	  met	  adrenaline 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
12. Mijn	  incisie(s)	  bij	  de	  voorwandplastiek	  maak	  ik:	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   In	  de	  mediaanlijn	  van	  urethraal	  naar	  cervicaal	  of	  vaginatopwaarts 
	  	  	  	  	   T-­‐vormige	  incisie	  van	  cervix/top	  richting	  urethra 
	  	  	  	  	   Ruitvormig 
	  	  	  	  	   Ellipsvormig 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
13. Het	  meest	  urethrale	  punt	  van	  mijn	  incisie	  ligt:	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   Minder	  dan	  één	  cm	  vanaf	  de	  meatus	  urethrae 
 	  	  	  	  	   Dicht	  bij	  de	  urethrovesicale	  overgang 
 	  	  	  	  	   Lager	  dan	  de	  urethrovesicale	  overgang 
 	  	  	  	  	   Ik	  laat	  het	  afhangen	  van	  de	  eventueel	  aanwezige	  stress	  incontinentie 
 	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
Vrijprepareren	  
	  
14. Om	  de	  blaas	  vrij	  te	  preparen	  gebruik	  ik:	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Mes 
	  	  	  	  	   Schaar 
	  	  	  	  	   Stomp 
	  	  	  	  	   Diathermie 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
15. Streeft	  u	  er	  naar	  de	  vaginawand	  zo	  dun	  mogelijk	  van	  de	  blaas	  af	  te	  prepareren?	  
(let	  wel	  het	  gaat	  niet	  over	  een	  mesh)	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Ja,	  ik	  maak	  daar	  veel	  werk	  van 
	  	  	  	  	   Alleen	  als	  het	  zo	  uitkomt 
	  	  	  	  	   Ik	  vind	  het	  niet	  belangrijk	  en	  prepareer	  in	  het	  meest	  optimale	  chirurgische	  vlak 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
Pliceren	  
	  
16. Welk	  hechtmateriaal	  gebruikt	  u	  als	  regel	  om	  de	  blaas(fascie)	  te	  pliceren?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Vicryl 
	  	  	  	  	   Vicryl	  rapide 
	  	  	  	  	   Monocryl 
	  	  	  	  	   PDS 
	  	  	  	  	   Proleen 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
17. Welke	  dikte	  heeft	  dit	  hechtmateriaal?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   0 
	  	  	  	  	   1 
	  	  	  	  	   2-­‐0 
	  	  	  	  	   3-­‐0 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
Trimmen	  vaginawanden	  bij	  voorwandplastiek	  	  
	  
18. Na	  plicering	  trim	  ik	  de	  vaginawanden:	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Nooit 
	  	  	  	  	   Altijd 
	  	  	  	  	   Afhankelijk	  van	  het	  overtollig	  weefsel 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
Sluiten	  vagina	  epitheel	  bij	  de	  voorwandplastiek	  
	  
19. Ik	  sluit	  de	  vagina	  wand:	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Geknoopt 
	  	  	  	  	   Doorlopend	  gefestonneerd 
	  	  	  	  	   Doorlopend	  niet	  gefestonneerd 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
Postoperatief	  beloop	  voorwandplastiek	  
	  
20. Een	  tampon	  gebruik	  ik:	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   Altijd 
 	  	  	  	  	   Bij	  bloeding 
 	  	  	  	  	   Bij	  combinatie	  met	  achterwandplastiek 
 	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
21. Ik	  verwijder	  de	  tampon	  als	  regel	  op	  (dagen	  na	  de	  operatie):	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Dag	  1 
	  	  	  	  	   Dag	  2 
	  	  	  	  	   Dag	  3 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
22. Ik	  gebruik	  meestal	  als	  catheter:	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Transurethrale	  catheter 
	  	  	  	  	   Suprapubische	  catheter 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
23. Ik	  laat	  de	  catheter	  gewoonlijk	  in	  situ	  voor	  (aantal	  dagen):	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   1	  dag 
 	  	  	  	  	   2	  dagen 
 	  	  	  	  	   3	  dagen 
 	  	  	  	  	   4	  dagen 
 	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
24. Het	  maximale	  residu	  dat	  ik	  accepteer	  na	  een	  voorwandplastiek	  is:	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   50	  cc  
 	  	  	  	  	   100	  cc  
 	  	  	  	  	   150	  cc  
 	  	  	  	  	   200	  cc  
 	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	    
	  
	  
25. Bij	  een	  ongecompliceerd	  verloop	  worden	  mijn	  patiënten	  na	  een	  
voorwandplastiek	  ontslagen	  op:	  
	  	  	  	  	   Dag	  1  
	  	  	  	  	   Dag	  2  
	  	  	  	  	   Dag	  3  
	  	  	  	  	   Dag	  4  
	  	  	  	  	   Dag	  5  
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	    
	  	  
	  
26. Heeft	  u	  nog	  aanvullingen	  in	  de	  techniek	  die	  wellicht	  van	  belang	  zijn	  en	  nog	  niet	  
genoemd?	  
	   	  	  	  	  	  	  	  
	  
	   	  
	  
Enquête	  gebruik	  kunststofmateriaal	  bij	  vaginale	  prolapschirurgie	  
	  
We	  zijn	  ook	  geïnteresseerd	  in	  uw	  mening	  ten	  opzichte	  van	  het	  gebruik	  van	  (niet	  
resorbeerbaar,	  niet	  biologisch)	  uitsluitend	  vaginaal	  gebruik	  van	  kunststofmateriaal	  (dus	  
niet	  voor	  sacropexie)	  
	  
27. Gebruikt	  u	  überhaupt	  kunststofmateriaal	  bij	  vaginale	  prolapschirurgie?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Ja  
	  	  	  	  	   Nee 	  	  	  ⇒	  Volgende	  vraag:	  35 
	  
28. Kunt	  u	  aangeven	  welk	  percentage	  van	  de	  vaginale	  prolapschirurgie	  u	  
kunststofmateriaal	  gebruikt?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   0-­‐5	  % 
	  	  	  	  	   5-­‐10	  % 
	  	  	  	  	   10-­‐20	  % 
	  	  	  	  	   20-­‐40	  % 
	  	  	  	  	   40-­‐60	  % 
	  	  	  	  	   60-­‐80	  % 
	  	  	  	  	   80-­‐100	  % 
	   	  
	  
29. Kunt	  u	  aangeven	  welke	  indicaties	  u	  onderschrijft?	  (meer	  dan	  één	  antwoord	  
mogelijk)	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Ik	  gebruik	  in	  principe	  bij	  alle	  vaginale	  prolapsoperaties	  kunststofmateriaal 
	  	  	  	  	   
Ik	  gebruik	  kunststofmateriaal	  alleen	  bij	  recidief	  na	  eerdere	  prolapschirurgie	  als	  deze	  in	  het	  zelfde	  
compartiment	  optreedt 
	  	  	  	  	   
Ik	  gebruik	  kunststofmateriaal	  alleen	  bij	  recidief	  na	  eerdere	  prolapchirurgie	  ook	  als	  deze	  NIET	  in	  het	  
eerder	  geopereerde	  compartiment	  optreedt 
	  	  	  	  	   Ik	  gebruik	  kunststofmateriaal	  alleen	  als	  er	  meer	  dan	  één	  recidief	  is	  opgetreden 
	  	  	  	  	   Ik	  gebruik	  kunststofmateriaal	  alleen	  als	  er	  een	  snel	  recidief	  is	  opgetreden 
	  	  	  	  	   
Ik	  gebruik	  kunststofmateriaal	  ,	  ook	  bij	  een	  niet	  eerder	  geopereerde	  patiënt	  ,	  als	  er	  duidelijk	  een	  
verhoogd	  risico	  op	  recidief	  is 
	  
30. Wat	  beschouwt	  u	  als	  duidelijk	  verhoogd	  risico	  op	  recidief?	  (meer	  dan	  één	  
antwoord	  mogelijk)	  
	   	  	  	  	  	  	  	  
 	  	  	  	  	   Oude	  leeftijd 
 	  	  	  	  	   Jonge	  leeftijd 
 	  	  	  	  	   Hoog	  stadium	  prolaps 
 	  	  	  	  	   Meerdere	  compartimenten	  betrokken 
 	  	  	  	  	   Laterale	  defecten 
 	  	  	  	  	   Centrale	  defecten 
 	  	  	  	  	   “op	  het	  klinisch	  oog” 
 	  	  	  	  	   Sterk	  verhoogde	  BMI 
 	  	  	  	  	   COPD 
 	  	  	  	  	   Roken 
 	  	  	  	  	   Bindweefselziekte	  (bijv	  Ehlers	  /Danlos) 
 	  	  	  	  	   Positieve	  familieanamnese 
 	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
 	  	  	  	  	   Geen	  van	  bovenstaande 
	  
31. Geeft	  u	  bij	  mesh-­‐gebruik	  lokale	  of	  systemische	  oestrogenen	  bij	  postmenopauzale	  
vrouwen?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Nooit 
	  	  	  	  	   Alleen	  op	  indicatie 
	  	  	  	  	   Meestal 
	  	  	  	  	   Altijd 
	  
32. Indien	  u	  kunststofmateriaal	  gebruikt	  welk	  materiaal	  gebruikt	  u	  dan?	  
(bijvoorbeeld:	  als	  u	  80	  %	  prolift	  en	  20	  %	  avaulta	  gebruikt,	  vul	  dan	  respectievelijk	  
8	  bij	  prolift	  en	  2	  bij	  avaulta	  in)	  
	   	  	  	  	  	  	  	  
 
	  	  	  	  	   Prolift 
 
	  	  	  	  	   Avaulta 
 
	  	  	  	  	   Perigee/Apogee 
 
	  	  	  	  	   Anders,	  namelijk 
	   	  
	  
33. Geeft	  u	  standaard	  antibiotica	  profylaxe	  bij	  mesh	  gebruik?	  
	  	  	  	  	   Ja 
	  	  	  	  	   Nee 
	  
34. Wisselt	  u	  standaard	  handschoenen	  voor	  het	  inbrengen	  van	  de	  mesh?	  
	  
	  	  	  	  	   Ja 
	  	  	  	  	   Nee 
	   	  
	  
We	  willen	  u	  als	  laatste	  nog	  een	  paar	  vragen	  stellen	  over	  de	  POP-­‐Q	  score.	  
	  
35. Gebruikt	  u	  de	  POP-­‐Q	  score?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Ja  
	  	  	  	  	   Nee 	  	  	  ⇒	  Einde	  enquête 
	  
36. Gebruikt	  u	  de	  POP-­‐Q	  score	  routine	  of	  op	  indicatie	  (bijv	  voor	  onderzoek)	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Routine 
	  	  	  	  	   Op	  indicatie 
	  
37. Aangezien	  er	  veel	  kritiek	  is	  op	  de	  POP-­‐Q,	  kunt	  u	  aangeven	  of	  u	  de	  volgende	  
stellingen	  deelt?	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   POP-­‐Q	  is	  moeilijk	  te	  leren	  (ingewikkeld)	   
	  	  	  	  	   POP-­‐Q	  is	  tijdrovend 
	  	  	  	  	   POP-­‐Q	  meet	  een	  aantal	  overbodige	  parameters 
	  	  	  	  	   POP-­‐Q	  heeft	  geen	  klinische	  nut 
	  	  	  	  	   Anders,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  	  	  	  	   Ik	  ben	  met	  het	  met	  geen	  van	  bovenstaande	  stellingen	  eens. 
	  
38. Heeft	  u	  suggesties	  voor	  een	  betere	  score?	  	  
	   	  	  	  	  	  	  	  
	  	  	  	  	   Nee 
	  	  	  	  	   Ja,	  namelijk	  	   	  	  	  	  	  	  	  	   
	  
	  
	   	  	  	  	  	  	  	  
We	  willen	  u	  hartelijk	  danken	  voor	  het	  invullen	  van	  deze	  enquête.	  


CDankwoord
Ik ben veel mensen dank verschuldigd. Zonder hen was ik nooit gepromoveerd en zou
een grote droom, gynaecoloog worden, misschien wel nooit kunnen uitkomen. Een aantal
wil ik graag persoonlijk noemen.
Ik heb ontzettend geboft met mijn promotor en co-promotores en wil ze dan ook in
het bijzonder bedanken:
Professor Vierhout, beste Mark, sinds oktober 2009 staan er 961 e-mails in mijn
postvak met een gemiddelde reactietijd van 1,8 dag (mediaan 1,6). Deze statistiek zegt
meer dan 1000 woorden. Een betere promotor kan ik me eerlijk gezegd niet voorstellen.
Je bent altijd eerlijk, oprecht en laagdrempelig benaderbaar. Het klinkt als een cliche´,
maar zonder jou was ik echt nooit gaan promoveren en was ik nooit zo ver gekomen. Ik
vind het heel erg jammer dat ik niet meer in de kliniek van je kan leren.
Beste Marie¨lla, jouw enthousiasme vanaf het allereerste artikel zorgde ervoor dat ik
nooit heb getwijfeld of dingen wel ’klinisch relevant’ waren. En ook jouw reactietijd doet
niets onder voor die van Mark. Als ik er af en toe toch niet uitkwam met de statistiek of
het bestand, kon je me met een half woord weer op weg helpen.
Beste Kirsten. Het duurde even voordat ik er achter kwam wie er precies achter de
kritische e-mails en correcties zat, maar je bent een waardevolle aanvulling geweest voor
het team. Mede door jou ben ik beter Engels gaan schrijven en ik hoop nog veel van je
te kunnen leren in de praktijk.
Beste Fred. Als laatste werd jij toegevoegd aan het team, en niet onterecht. Veel
data van mijn artikelen heb ik te danken aan de nauwe samenwerking tussen Delft en
Nijmegen. Jouw enthousiasme en snelheid werkte aanstekelijk!
Beste Jackie. Nadat ik in oktober 2009 niet aangenomen was in een sollicitatieronde,
werd het me duidelijk dat ik meer onderzoek moest gaan doen. Ik vergeet het niet meer
dat ik in de vissenkom aan jou vroeg of jij niet iemand kende bij wie ik onderzoek kon
doen in de bekkenbodem. Die kende je wel, en jij zorgde voor het eerste contact tussen
mij en prof Vierhout. Je bent tevens betrokken geweest bij een aantal artikelen en was
altijd beschikbaar voor vragen in de wandelgangen waardoor ik weer snel verder kon.
Je bent voor mij een groot voorbeeld als gynaecoloog en ben heel blij dat je op deze
bijzondere dag mij wilt bijstaan als paranimf.
Alle gynaecologen van het CWZ Nijmegen: dr. Bos, dr. Franssen, dr. van Heteren,
dr. de Kruif, dr. Schippers, dr. Sporken en dr. Snijders. Wat heb ik me altijd thuis
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gevoeld in het CWZ en wat heb ik al veel geleerd. Ik ben heel erg blij dat ik de rest van
mijn opleiding bij jullie mag volgen.
Alle gynaecologen van het Catharina Ziekenhuis Eindhoven: dr. Hasaart, dr. van der
Putten, dr. Kuppens, dr. Dietz, dr. Hermans, dr. Schoot en dr. van Dop. Het was
fijn om bij jullie als ANIOS te mogen beginnen en de eerste kneepjes van het vak te
leren. Dr. Hasaart, bedankt voor het gestelde vertrouwen en ik zal de vraag tijdens mijn
sollicitatiegesprek: ’kun je ook een schilderij ophangen met een klopboor?’ nooit meer
vergeten. Dr. Dietz en dr. Hasaart bedankt voor het sparen van de ’voorwandjes’ en het
meewerken aan hoofdstuk 4.
Beste Saskia van den Berg-van Erp. Hoofdstuk 4 zou er zonder jouw hulp en vertrouwen
niet zijn geweest. Toen ik met het idee kwam om voorwandjes met elkaar te gaan
vergelijken was je direct enthousiast want je hield wel van ’simpele klinisch relevante
dingen uitzoeken’. Supersnel heb je alle voorwandjes bekeken en opgemeten.
Collega (oud) arts-assistenten CWZ. Bedankt voor de gezelligheid en de collegialiteit.
Marjolijn en Joyce, we moeten die etentjes er wel inhouden he`!
Collega (oud) arts-assistenten Catharina Eindhoven. Bedankt dat ik van jullie dit
mooie vak heb mogen leren. Ook hier heb ik me altijd thuis gevoeld.
Verloskundigen, verpleegkundigen en poli-assistenten van het CWZ en het Catharina.
Dank vooral voor het vertrouwen dat ’ik er echt wel eens ging komen’. Dit maakte
veel goed als ik weer niet was aangenomen in een sollicitatieronde. Ook dank voor alle
gezellige nachtdiensten waarin jullie soms rustig meediscussieerden over mijn onderzoek.
En natuurlijk dank dat jullie er altijd voor zorgen dat ik met beide benen op de grond
blijf staan.
Gynaecologen, IVF-artsen, embryologen, analisten, secretaresses, verpleegkundigen
en iedereen die ik vergeet te noemen van de -1. Ik heb met heel veel plezier ruim 1
jaar gewerkt als IVF-arts in het Radboud, waarbij ik veel vrije tijd over hield om een
eindsprint te kunnen maken voor mijn promotie-onderzoek.
De nonnen van Vught, Regina Coelie, waar ik in maart 2010 een individuele taalcursus
heb gevolgd. Zonder dit programma was het me nooit gelukt de artikelen in fatsoenlijk
Engels te schrijven.
Oom Adrie en Odet de Graaff. Bedankt voor het aanleveren van de mooie gereefde
zeilfoto’s.
Smullerijgroep, lieve Tommy, Moniek, Roel, Marieke, Thom, Kristel, Paul, Jessica,
Bram en Katja. Bedankt dat jullie probeerden te begrijpen waar ik toch in godsnaam
mee bezig was. De 2-maandelijkse etentjes werken nog steeds als een perfecte ontspanning
en hoop dat we dat nog lang zullen volhouden.
Lieve Anoek. Vanaf een jaar of 10 zijn we al vriendinnen. Onze levens lopen verba-
zingwekkend synchroon, terwijl we het toch allebei op onze eigen manier doen. Ik ben
zeker niet de meest attente vriendin, maar je hebt me nooit het idee gegeven dat je me
dat kwalijk nam. Als ik het niet meer zag zitten qua opleiding of promotie, praatte je
me er altijd weer bovenop. Dankjewel en hoop dat we nog heel lang vriendinnen zullen
160
CDankwoord
blijven.
Rob & Carin, Bas & Eelke, Maud, Tijn en Tessel. Bedankt dat jullie keer op keer
probeerden te begrijpen waar ik toch mee bezig was.
Lieve Bas. Ik weet dat jij stiekem hartstikke trots bent op je grote zus en dat doet
veel goed.
Lieve Saskia. Eigenlijk was jij tegen ’artsenpromoties’ maar je hebt me altijd gesteund
in mijn traject. Je Engelse correcties waren verschrikkelijk fijn en goed (als een native
speaker). Ik bof maar met zo’n schoonzus.
Lieve Rob. Naast mezelf en de mede-auteurs, heb jij de meeste uren in dit boekje
zitten. Wat bof ik toch met een broer die zo handig is met computers. Vanaf mijn jeugd
pluk ik daar al de vruchten van en nu nog het meest. Zonder jou was dit boekje absoluut
niet zo mooi geworden en ik ben er hartstikke trots op dat we dit zelf hebben kunnen
maken.
Lieve Theo en Pieternel. Als ik enthousiast vertelde dat er weer een artikel was
geaccepteerd, waren jullie net zo enthousiast ook al begrepen jullie niet altijd waar het
nu precies om ging. Theo, wat vind ik het verschrikkelijk jammer dat ik niet meer met
jou kan toosten met een goed glas wijn op deze heugelijke dag. Pieternel, wat ben je toch
een sterke schoonmoeder en zitten aan de keukentafel voelt nog steeds als thuiskomen.
Lieve papa en mama, ons pap en ons mam. Al vanaf de middelbare school hebben
jullie alle vertrouwen in mij gehad, ook al kwam er dat niet altijd uit. Nooit getwijfeld
of ik wel VWO-in-1-jaar zou aankunnen, nooit getwijfeld of de universiteit niet te hoog
gegrepen zou zijn. Ik mocht studeren wat ik wilde, waar ik maar wilde. Financieel
hebben jullie altijd met alles geholpen en doen dat desnoods nog steeds. En ik besef dat
ik daar enorm mee bof. Lieve mama, je leefde vanaf het begin van het onderzoek enorm
mee en was overal van op de hoogte. Ik kan soms enorm mopperen op jou, maar dat
komt waarschijnlijk omdat we toch veel op elkaar lijken. Lieve papa, je zal het nooit
echt zeggen, maar ik weet dat je hartstikke trots bent. Dat stukje in de Volkskrant over
de bekkenbodem oid wist jij altijd weer netjes te bewaren. Dankjewel.
Liefste Tom. Wat ben ik toch blij met jou, jij maakt mij een stukje beter. Zonder
jou was dit boekje er nooit gekomen en had ik de handdoek allang in de ring gegooid.
Altijd vertrouwen, nooit gemopperd waarom het toch allemaal zo lang duurt. Elk artikel
heb jij als eerste gelezen en durf oprecht te zeggen dat jij meer over de voorwandplastiek
weet dat de gemiddelde gynaecoloog. Jouw rust en relativeringsvermogen zijn precies de
dingen die ik nodig heb, zeker vandaag, als jij als mijn paranimf naast mij staat.
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DCurriculum Vitae
Ellen Lensen werd op 25 mei 1982 geboren in het Brabantse Oss en groeide hier op
samen met haar broers Rob en Bas. In 1999 haalde zij haar HAVO-diploma aan het
Mondriaan College te Oss en in 2000 het VWO-diploma aan de ROC in Nijmegen. Toen
ze was uitgeloot voor Geneeskunde, heeft ze e´e´n jaar Psychologie gestudeerd aan de
Radboud Universiteit in Nijmegen. In 2001 was het lot haar gunstiger gestemd en kon
ze beginnen met de opleiding Geneeskunde aan de Erasmus Universiteit in Rotterdam.
Omdat gynaecologie al tijdens de studie haar interesse wekte, heeft ze in het 4e jaar een
afstudeeronderzoek naar het herhalingsrisico van pre-eclampsie verricht (dr. W. Visser).
Alle co-schappen werden met veel plezier gelopen in het St. Elisabeth Ziekenhuis te
Tilburg. Het oudste co-schap vond plaats bij een Nederlandse gynaecoloog (dr. Y. Rijken)
in Malawi, Afrika. Na haar studie kon ze vrij snel aan de slag als ANIOS Gynaecologie
& Obstetrie in het Catharina Ziekenhuis te Eindhoven (opleider dr. T. Hasaart). Na
e´e´n jaar daar gewerkt te hebben, kon ze verder als ANIOS in het Canisius Wilhelmina
Ziekenhuis te Nijmegen (opleider dr. J. Sporken). Na een ANIOS-tijd van bijna 4 jaar,
begon ze als fertiliteits-arts in het UMC St Radboud, om zo ook meer tijd te kunnen
besteden aan het reeds gestarte promotie-onderzoek. In januari 2013 kon ze opnieuw als
arts-assistent aan de slag in het Canisius Wilhelmina Ziekenhuis te Nijmegen (opleider
dr. M. Snijders), waar ze 1 oktober de opleiding tot gynaecoloog zal beginnen. Ellen
Lensen is getrouwd met Tom van der Heijden.
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